Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Feb 19;16(2):e0247311. doi: 10.1371/journal.pone.0247311

Serotonin transporter genotype modulates resting state and predator stress-induced amygdala perfusion in mice in a sex-dependent manner

Jann F Kolter 1,2, Markus F Hildenbrand 3, Sandy Popp 2, Stephan Nauroth 2, Julian Bankmann 1, Lisa Rother 1, Jonas Waider 2, Jürgen Deckert 1, Esther Asan 4, Peter M Jakob 5, Klaus-Peter Lesch 2, Angelika Schmitt-Böhrer 1,*
Editor: Tamas Kozicz6
PMCID: PMC7895400  PMID: 33606835

Abstract

The serotonin transporter (5-HTT) is a key molecule of serotoninergic neurotransmission and target of many anxiolytics and antidepressants. In humans, 5-HTT gene variants resulting in lower expression levels are associated with behavioral traits of anxiety. Furthermore, functional magnetic resonance imaging (fMRI) studies reported increased cerebral blood flow (CBF) during resting state (RS) and amygdala hyperreactivity. 5-HTT deficient mice as an established animal model for anxiety disorders seem to be well suited for investigating amygdala (re-)activity in an fMRI study. We investigated wildtype (5-HTT+/+), heterozygous (5-HTT+/-), and homozygous 5-HTT-knockout mice (5-HTT-/-) of both sexes in an ultra-high-field 17.6 Tesla magnetic resonance scanner. CBF was measured with continuous arterial spin labeling during RS, stimulation state (SS; with odor of rats as aversive stimulus), and post-stimulation state (PS). Subsequently, post mortem c-Fos immunohistochemistry elucidated neural activation on cellular level. The results showed that in reaction to the aversive odor CBF in total brain and amygdala of all mice significantly increased. In male 5-HTT+/+ mice amygdala RS CBF levels were found to be significantly lower than in 5-HTT+/- mice. From RS to SS 5-HTT+/+ amygdala perfusion significantly increased compared to both 5-HTT+/- and 5-HTT-/- mice. Perfusion level changes of male mice correlated with the density of c-Fos-immunoreactive cells in the amygdaloid nuclei. In female mice the perfusion was not modulated by the 5-Htt-genotype, but by estrous cycle stages. We conclude that amygdala reactivity is modulated by the 5-Htt genotype in males. In females, gonadal hormones have an impact which might have obscured genotype effects. Furthermore, our results demonstrate experimental support for the tonic model of 5-HTTLPR function.

Introduction

The monoamine serotonin (5-hydroxtryptamine, 5-HT) is one of the key modulators of emotional states and cognitive processing. The 5-HT transporter (5-HTT) responsible for the re-uptake of synaptically released 5-HT into the presynaptic neuron is important for the fine-tuning of serotonergic neurotransmission and is a principal target of various antidepressants and anxiolytics [13]. In humans, variation of 5-HTT/SLC6A4 gene expression levels are mainly genetically driven by the 5-HTT gene-linked polymorphic region (5-HTTLPR) in the promotor. The short (S)-allele results in lower 5-HTT mRNA and protein levels and is shown to be associated with an increased risk for affective disorders and maladaptive behavioral traits [47]. Additionally, a single-nucleotide polymorphism in the long (L) variant affects 5-HTT availability with the LG variant resulting in nearly equivalent expression levels as the S variant [8].

To further deepen the knowledge of the influence of altered 5-HT neurotransmission on neurodevelopment and behavior the 5-HTT knockout (-/-) mouse model with a targeted disruption of the 5-Htt gene was generated [9]. 5-HTT-deficient mice exhibit many changes at the neurochemical/5-HT receptor level [1014], display increased anxiety-related behavior [15,16] and altered stress susceptibility [17,18], and therefore are established as an animal model for anxiety disorders and for 5-Htt gene-by-environment interaction studies[1921]. A previous study shows that olfactory perception is unaltered in 5-HTT-deficient mice [22].

Understanding of fear and anxiety disorders requires the elucidation of networks and processes that convert an aversive stimulus into a fear reaction irrespective of whether it is appropriate or not. The anxiety/fear network comprises several directly or indirectly connected regions and nuclei, including the amygdala, prelimbic and infralimbic cortex, bed nucleus of stria terminalis, hippocampus, and periaqueductal grey including the raphe nuclei [for review [23]]. Our research mainly focuses on the amygdala, as it is an important key player in the neurocircuitry of fear, stress, and anxiety disorders [24]. The amygdala, a complex structure consisting of several interconnected nuclei, receives numerous afferents from different brain regions including serotonergic afferents primarily originating in neurons of the dorsal and sparsely originating in neurons of the median raphe nuclei [2527]. The two main sub-areas of the amygdala are the striatum-like central nucleus of the amygdala (Ce) composed mainly of GABAergic neurons and the cortex-like basolateral amygdala (BLA) with around 80% glutamatergic principal neurons and roughly 20% GABAergic interneurons. The BLA is composed of the lateral (La) and basolateral (BL) nucleus [28,29].

Several behavioral responses important for the survival and reproduction of an organism like feeding, mating and escaping are known to be initiated and driven by odors. The medial nucleus of the amygdala receives olfactory information either by the vomeronasal or the main olfactory system [3033] Chemosensory information from both pathways is further transferred to the hypothalamus, nucleus accumbens and to the Ce and BLA [34]. Mice that are exposed to rat predator scents exhibit innate defensive behaviors including flight and freezing as well as an increase in stress hormone levels [3539]. Furthermore, predator odors were shown to evoke an increase in the immediate early gene (IEG) product c-Fos in the BL, Ce and medial nucleus in rodents [4042]. Increase in c-Fos protein expression occurs in response to direct stimulation of neurons and serves as marker for neuronal activation [4345].

In human fMRI studies, increased resting cerebral blood flow (CBF) in the amygdala and hippocampus of healthy 5-HTT/SLC6A4 S-allele carriers compared to L-allele carriers was demonstrated first by Canli and coworkers using arterial spin labeling (ASL) [46]. These findings were independently replicated for the amygdala using continuous ASL (CASL), whereas no difference in global CBF intensities was found across the two genotype groups [47]. Controversially to all these findings, Viviani and coworkers did not reveal an association between the 5-HTTLPR polymorphism and baseline brain perfusion in a cohort of 183 healthy individuals appying CASL [48].

Applying another technique, the blood oxygen level dependent (BOLD) contrast imaging, healthy individuals with one or two copies of the S allele exhibited greater BOLD signal change in the amygdala in response to the presentation of fearful and angry faces indicating increased neuronal activity in the amygdala of S allele carriers compared to the homozygous L allele group [[4953] for review: [54,55]]. Results of 99mTc-HMPAO-SPECT scans performed with patients suffering from major depression also pointed to an over(re)activity of the amydalae of the S-allele group relative to the L/L group [56].

Amygdala activity and reactivity to negative stimuli can be investigated in mice, as in humans, with the CASL method using magnetically labelled blood as an intrinsic marker to measure perfusion and signal changes in specific brain regions [57]. In the present study, the CASL approach was applied using an ultra-high-field 17.6 Tesla magnetic resonance imaging (MRI) system to investigate CBF and predator odor-induced perfusion changes in the amygdala and whole brain of male and female mice of different 5-Htt genotypes. As a marker for perfusion this study uses a perfusion level that indicates the proportion of perfusion relative to the overall signal intensity of each voxel, which represents a much less intereference-prone parameter. This approach extensively excludes any preexisting and constant conditions like subject specific blood supply, which might influence the measurements. Subsequently, quantitative immunohistochemistry for c-Fos was carried out to assess amygdala activation at the cellular level, combining, for the first time, ultra-high-field MRI at 17.6 T and IEG-based cellular activation mapping strategies. We hypothesized that rat odor-induced perfusion level changes and c-Fos-immunoreactivity in the rodent amygdala are differentially affected by 5-Htt genotype and sex.

Material and methods

Ethics statement

The present work complies with current regulations regarding animal experimentation in Germany and the EU (European Communities Council Directive 86/609/EEC). All procedures and protocols have been approved by the committees on the ethics of animal experiments of the University of Würzburg and of the Government of Lower Franconia (license 55.2–2531.01-81/10). Sacrifice was performed under deep isoflurane anesthesia. All efforts were made to minimize suffering.

Animals

Experimental subjects were 3–6 month-old 5-HTT homozygous knockout (5-HTT-/-), heterozygous knockout (5-HTT+/-) and wildtype (5-HTT+/+) mice originating from heterozygous mating pairs fully backcrossed onto C57BL/6J genetic background [9]. All animals were bred and housed in the animal facility of the Center for Experimental Molecular Medicine at the University of Wuerzburg under controlled conditions (12/12 h light-dark cycle, 21±1°C room temperature and 55±5% relative humidity) and with food and water provided ad libitum. Mice were genotyped by PCR using genomic DNA extracted from ear tissue.

Functional magnetic resonance imaging

General procedure

FMRI experiments were performed at the Department of Experimental Physics 5 (University of Wuerzburg) in cooperation with the Fraunhofer Development Center X-Ray Technology EZRT, Department of Magnetic Resonance and X-Ray Imaging on a wide-bore ultra-high-field magnet at 17.6 T (Bruker Avance 750 WB, Bruker BioSpin GmbH, Ettlingen, Germany) with a Bruker Mini 0.75 (300 mT/m) gradient system. As displayed in Table 1 fMRI was conducted on 29 male and 28 female mice that were exposed to rat odor as an unconditional fear-evoking stimulus. A subgroup of these mice was then used to evaluate the induction of c-Fos immunoreactivity in the amygdala. In addition, some mice (male: n = 3; female: n = 4) were exposed to a neutral odor and thus served as a negative control of c-Fos induction by rat odor.

Table 1. Age, body weight and number of mice used in fMRI and c-Fos experiments.
Male Female
+/+ +/- -/- +/+ +/- -/-
Age [mo, mean (min-max)] 4.9 (3.5–6.1) 5.4 (4.0–6.1) 5.0 (3.6–5.9) 5.4 (5.1–5.6) 5.4 (5.0–5.6) 5.4 (5.2–5.6)
BW [g, mean±SEM] 32.0 ± 1.3 33.9 ± 1.1 34.8 ± 1.6 24.4 ± 0.7a 25.6 ± 0.9a 29.9 ± 1.1b
fMRI [n] 8 9 12 9 9 10
c-Fos [n] 4 4 6 2 2 2

BW, body weight; mo, months; g, grams; n, number of mice

a: p<0.05 vs.

b. Additional control mice (neutral odor): 5-HTT+/+: male (n = 1), female (n = 1); 5-HTT+/-: male (n = 1); female (n = 1); 5-HTT-/-: male (n = 1), female (n = 2).

Animals were transported to the location with the 17.6 T scanner 24 h prior to the experiment to allow adaptation to the new environment to reduce stress.

All fMRI measurements were performed during the light phase between 9 AM and 7 PM. Males and females were tested independently, and the testing order was continuously alternated between the three genotypes to prevent potential time-of-day effects. Moreover, to control for sex hormone fluctuations in female mice, the individual estrous cycle stage was determined cytologically as described by McLean and coworkers directly before fMRI [58].

Odor preparation

Rat odor administered during fMRI was prepared from a 50 ml tube filled with male rat soiled bedding moistened with water and stored at -20°C to prevent loss of odorous substance. The frozen bedding was slowly defrosted right before initiation of the measurement. Neutral control odor was prepared the same way, but with unused bedding material.

Animal preparation

Mice were pre-anesthetized in their home cages with an induction level of 0.8% isoflurane (Forene®, Abbott, Switzerland) in compressed air (1.0 l/min) to prevent pre-experimental stress through slow sleep induction. The isoflurane concentration was then elevated to 4.0% by volume for up to 10 min to ensure deep anesthesia, important for subsequent fixation of the mice in supine position in a custom-made holder. Mice were fixed at four locations to prevent head movements in the scanner: Both ears with cotton buds, back of the head on a locating surface and teeth with a strand loop. The holder was positioned in a 38 mm diameter birdcage coil, which was used for radio-frequency transmission and signal reception. The percentage of isoflurane was decreased to 1.0% to maintain lower anesthesia during the experiment.

Vital sign monitoring

Respiration and heart rate were monitored throughout the experiment using an air-balloon positioned ventrally underneath the mouse thorax. The active temperature control of the MRI gradient system was used to maintain a constant environmental temperature of 37°C, which was monitored by a thermal sensor in the gradient system.

Experimental procedure

Structural and functional images of individual mice were registered onto a reference image selected from the measurements on the criteria of similarity to the image of the Allen Brain Mouse Atlas of the same sectional plane. This was done to compensate for anatomical- and geometrical-dependent differences between the subjects and to use one uniform regions of interest (ROI) layout in order to eliminate the error of individual ROI drafting.

The experimental procedure consisted of eight 10 min perfusion measurement blocks each comprising of 10 labeled and 10 unlabeled MRI acquisitions. As displayed in Fig 1, three 10 min blocks were acquired during the resting state (RS), two blocks during the stimulation state (SS) and three blocks during the post-stimulation state (PS). To prevent habituation, rat (or neutral) odor was applied automatically every two seconds as an air blast of one second duration by adding it to the constant stream of air/isoflurane-mixture during SS. Two hours after SS onset, mice were sacrificed, according to IACUC standards, by cervical dislocation following a deep anesthesia with isoflurane. Brains were then immediately dissected and processed for subsequent c-Fos immunohistochemical analyses.

Fig 1. Time course of the fMRI experiment.

Fig 1

Mice were allowed to habituate to the new environment in the adaption phase 24 h prior to the fMRI measurements. Resting state (RS, 30 min), stimulation state (SS, 20 min) and post-stimulation state (PS, 30 min) measurements comprising of separate 10 min blocks were performed on anesthetized mice. Each block consisted of 10 labeled/unlabeled MRI acquisition pairs. Two hours (120 min) after initiation of aversive or neutral odor presentation brains were dissected and processed for subsequent immunohistochemical stainings with the c-Fos antibody (c-Fos IHC).

Perfusion MRI with continuous arterial spin labeling

CASL measurements were performed with a modified single coil method using a turbo spin-echo imaging sequence [5961] already described as applicable for perfusion measurements in animal models of ischemic stroke [62]. CASL parameters are described in detail by Pham and coworkers [63]. An in-house built transmit/receive linear birdcage resonator coil with an inner diameter of 38 mm was used.

Rostral to caudal adjustment of the image plane for perfusion measurements was accomplished with coronal orientated scout images [Rapid Acquisition with Refocused Echoes (RARE), echo train length (ETL) = 20, effective echo time TEeff = 9.43 ms, repetition time TR = 7.5 s, slice thickness = 1.0 mm, number of slices = 3, field of view (FOV) = 4.0×4.0 cm, matrix of 180×180 voxels] for each animal to assure that most parts of the amygdala were within the measuring plane. The aim was to adjust the head of the mouse in a position so that the scout image was at the best rate equivalent to Bregma level -1.22 mm [64].

A radio frequency (RF) pulse located 1.4 cm away from the imaging plane based on the tagging-gradient was applied for the adiabatic inversion of arterial blood in the neck. Compensation of magnetization transfer effects was achieved by reversing the tagging-gradient before acquisition of the corresponding non-inverted control image.

RARE parameters were: ETL = 8, TEeff = 28.88 msec, TR = 1.0 sec, slice thickness = 1.5 mm, FOV = 1.68×1.68 cm with a matrix of 64×64 voxels. Alternating acquisition of measurements with the blood being labeled and unlabeled was repeated 10 times, resulting in a block measurement time of 10 min. All acquisitions were post-processed using MATLAB® (The Mathworks Inc., Natick, MA, USA). Images were screened for artifacts e.g. reflecting mouse head movements to prevent distorted perfusion measurements. The block-wise averaged labeled and unlabeled images were subtracted from each other and the difference representing the perfusion was then divided by the unlabeled image to finally obtain the perfusion level. The signal intensity of the unlabeled images is proportional to the amount of protons (e.g. blood) which is influenced by all kind of effects that target blood and water content as well as influences such as receiver amplification and field homogeneity which may differ for each measurement. The perfusion level indicates the proportion of perfusion relative to the overall signal intensity of each voxel, which represents a much less intereference-prone parameter. This approach extensively excludes any preexisting and constant conditions like subject specific blood supply, which might influence the measurements.

These block-wise maps were averaged again for each state to create one map per state. In order to eliminate differences in brain geometry, an anatomic image of each mouse underwent an image registration with the algorithm of Periaswamy and Farid [65,66]. The individual registration vector map was then applied to all corresponding images and maps in order to use one ROI layout for all mice to minimize inter-individual errors.

Both, percental perfusion level changes from RS to SS and SS to PS were calculated for each animal using following calculation: SS/RS x 100 or PS/SS x 100.

Image analysis

ROIs, i.e. total brain and the amygdaloid region comprising La, BL and Ce (termed as “amygdala” in the following), were defined in the consolidated image of all registered mouse brains as indicated in the mouse brain atlas of Franklin and Paxinos at Bregma level -0.94 mm to -1.82 mm (see Fig 2) [64].

Fig 2. Consolidated mouse brain image with defined regions of interest.

Fig 2

Total brain in dashed white lines and amygdala (comprising the lateral, basolateral and central amygdaloid nucleus) in solid white lines.

Quantitative immunohistochemistry for the detection of c-Fos protein

Tissue preparation

Brains were fixed in 4% PFA (dissolved in 1xPBS, pH 7.5) for 48 h. After treatment with sucrose brains were frozen in dry ice cooled isopentane and stored at -80°C. Finally, they were cut into coronal sections of 50 μm thickness, subsequently split into 6 series (each consisting of up to 7 slices with amygdala), and preserved in a cryoprotectant solution at -20°C for later use.

c-Fos immunohistochemistry

c-Fos immunohistochemistry was performed using the polyclonal antibody against c-Fos (made in rabbit, Santa Cruz, 1:8000; sc-52; unfortunately, this antibody has been discontinued in the meantime), applying the ABC method and 3,3´-diaminobenzidin as the substrate of the peroxidase according to the procedure described by [18]. No-Primary-Controls with omitting primary antibody incubation were performed and always resulted in the absence of any staining. In addition, positive-tissue-controls had been performed to verify the specifity of c-Fos immunoreactivity at the sub-cellular, cellular, and regional level.

Quantification of c-Fos-immunoreactive cells

For quantitative estimation of c-Fos-ir cells the Stereo Investigator 11 software was used in combination with a Neurolucida Microscope system from MBF Biosciences (Williston, USA). The experimenter blind for the 5-Htt genotypes individually traced the area of La, BL, and Ce, counted c-Fos-immune-positive cells, and calculated the relative cell density (cells per μm2). Finally, c-Fos-ir cell densities of every section were averaged for each animal.

Data analysis

All data were analyzed using SPSS Statistics version 23 (IBM Corporation, New York, USA). GraphPad Prism software version 6 (GraphPad Software, La Jolla, California, USA) was used for data graphing.

Comprehensive preliminary analyses were carried out to determine whether data met the assumptions of parametric tests. Data sets were visually inspected via boxplots to examine symmetry, skew, variance and outliers. Additionally, the Shapiro-Wilk test of normality and Levene’s test for homogeneity of variances were performed (S1 and S3 Tables). In ANOVAs with repeated measures Mauchly’s test was applied to determine whether the assumption of sphericity has been met. Cerebral perfusion level data obtained from CASL-based fMRI scans were analyzed by two-way mixed ANOVA with 5-Htt genotype as between-subjects factor and phase (RS, SS, PS) as within-subjects factor. In females, estrous cycle (proestrus vs. other stages) was included as an additional between-subjects factor. Relative perfusion level changes across the distinct fMRI phases were calculated as a fraction of one another (SS/RS, PS/RS, PS/SS) and analyzed by regular ANOVAs with genotype (and estrous cycle in females) as factor(s). The same statistical procedure was applied for the analysis of c-Fos-ir cell densities in the amygdala. Significant interactions were followed up with simple main effects analyses and Bonferroni post hoc tests for pairwise comparisons. Where applicable, Welch’s ANOVA and Games-Howell post-hoc tests were used.

The Pearson correlation coefficient was performed to determine the relationship between rat odor-induced amygdala perfusion levels and c-Fos-ir cell densities in the La, BL and Ce.

The chi-square test was used to check whether the two variables estrous cycle stage and 5-Htt genotype are statistically independent.

Data are shown as means ± standard errors of the mean (SEM) unless stated otherwise. Significance levels are indicated as #p<0.1, *p<0.05, **p<0.01 and ***p<0.001.

Results

Resting state perfusion and odor-induced perfusion level changes in the amygdala of male mice are influenced by 5-Htt genotype

Statistical results are summarized in S1 Table. Two-way mixed ANOVA on local perfusion in the amygdala of males (Fig 3A) yielded a strong main effect of phase (F(2,52) = 35.626, p<0.0001) along with a significant phase x genotype interaction (F(4,52) = 2.611, p = 0.046). Simple main effects analyses showed that, on the one hand, the interaction was driven by a strong genotype effect on RS perfusion (F(2,15.9) = 6.810, p = 0.007). Post hoc tests revealed significantly elevated RS perfusion levels in 5-HTT+/- mice as compared to 5-HTT+/+ (p = 0.012; brackets with dashed lines in Fig 3A). 5-HTT-/- mice exhibited intermediate RS perfusion values that were indistinguishable from those of 5-HTT+/- and 5-HTT+/+ littermates (p = 0.176 and p = 0.148, respectively). Neither SS nor PS perfusion levels differed among 5-Htt genotypes (F(2,15.3) = 1.743, p = 0.208 and F(2,26) = 0.936, p = 0.405, respectively). On the other hand, the interaction could be explained by a genotype-dependent difference in the magnitude of odor-induced signal change. Specifically, the increase in amygdala perfusion upon odor stimulation (RS→SS) was highest in 5-HTT+/+ (p<0.0001), intermediate in 5-HTT-/- (p = 0.009) and lowest in 5-HTT+/- (p = 0.069) mice. Similarly, PS perfusion level was significantly elevated above baseline (RS→PS) in 5-HTT+/+ (p<0.0001), 5-HTT-/- (p<0.0001) and 5-HTT+/- (p = 0.023) mice.

Fig 3. CBF perfusion levels in the amygdala of male mice are influenced by the 5-Htt genotype.

Fig 3

A: Cerebral perfusion levels during resting state (RS), stimulation state (SS) and post-stimulation state (PS) in the amygdala of male mice of all three 5-Htt genotypes. Data represent mean perfusion level ± SEM; Statistical analysis was performed using two-way mixed ANOVA with genotype (5-Htt+/+, 5-Htt+/-, 5-Htt-/-) as between-subjects factor and phase (RS, SS, PRS) as within-subjects factor. Bonferroni post hoc tests were applied for pairwaise comparisons. As with RS and SS perfusion data the assumption of homogeneity of variance is violated Welch`s ANOVA was applied for testing genotype effects in these two phases followed by Games-Howell post hoc tests. Significant differences between the SS or PS state compared to the RS state within the separate genotype groups are indicated. The bracket with dashed lines point to genotype-dependent differences of RS perfusion levels. *** p < 0.001, ** p ≤ 0.01, * p ≤ 0.05, # p ≤ 0.1. B: Data points represent individual percental increase in amygdala CBF levels in male 5-HTT+/+, +/- and -/- mice from RS to SS and mean percental increase ± SEM. C: Data points represent individual percental increase in amygdala CBF levels in male 5-HTT+/+, +/- and -/- mice from RS to PS and mean percental increase ± SEM; Statistical analysis using one-way ANOVA with genotype as between-subject factor and Bonferroni post hoc test. ** p ≤ 0.01, * p ≤ 0.05. D: Visual representation of perfusion level changes from RS to SS in male mice of different 5-Htt genotypes during aversive odor presentation. Individual voxel-based calculation of amygdala perfusion level changes depicted in colors corresponding to different values.

Accordingly, when SS and PS perfusion levels were expressed as a fraction of resting state perfusion level (SS/RS and PS/RS, respectively), ANOVA detected a highly significant genotype effect on both SS/RS (F(2,26) = 5.848, p = 0.008) and PS/RS (F(2,26) = 7.201, p = 0.003). Post-hoc tests indicated that both measures were significantly increased in 5-HTT+/+ mice relative to 5-HTT+/- (p≤0.01) and 5-HTT-/- (p<0.05) littermates (Fig 3B and 3C). Conversely, the PS/SS ratio did not significantly differ between genotypes (F(2,26) = 0.112, p = 0.894). Fig 3D visualizes percental signal changes from RS to SS, as individual percental signal changes were calculated for each voxel in the ROI amygdala and according to their value they were plotted in the corresponding intensity.

Analysis of whole-brain perfusion yielded a highly significant main effect of phase (F(2,52) = 46.573, p<0.0001), but no genotype main effect (F(2,26) = 3.031, p = 0.066) or an interaction between these two factors (F(4,52) = 1.860, p = 0.131; S1 Fig, S1 Table).

Odor-induced c-Fos immunoreactivity in the amygdala of male mice is influenced by 5-Htt genotype

Amygdalar cellular activation upon rat odor exposure during fMRI scans was assessed by quantitative analysis of c-Fos-ir cells in the La, BL and Ce of male mice two hours after stimulus onset (Fig 4C, 4E and 4G). We detected significant genotype effects on c-Fos-ir cell density in all three subnuclei (La: F(2,6.09) = 6.530, p = 0.031; BL: F(2,11) = 15.594, p = 0.001; Ce: F(2,11) = 8.881, p = 0.005). Post hoc tests indicated significantly increased c-Fos immunoreactivity in the amygdala of 5-HTT+/+ mice compared to 5-HTT+/- (La: p = 0.053, BL: p = 0.003, Ce: p = 0.016) and 5-HTT-/- (La: p = 0.040, BL: p = 0.001, Ce: p = 0.007) littermates.

Fig 4. The density of c-Fos-immunoreactive cells in three amygdaloid nuclei, which is influenced by 5-Htt genotype, correlates with the percental signal change from resting state to stimulation state.

Fig 4

(A,B): Representative image of c-Fos immunostaining in a brain section of a male mouse, which received the aversive odor (A) or the neutral odor (B) during fMRI experiment. c-Fos-ir cells are discernible by means of a clear brown nucleus staining. Scale bar in A represents 250 μm for A and B, and 25 μm in the inset in A. Lateral nucleus, La; basolateral nucleus, BL; central nucleus, Ce. (C,E,G): Data points represent individual and mean± SEM density of c-Fos-immunoreactive cells (number of c-Fos-ir cells per μm2) in the lateral, basolateral and central amygdaloid nucleus of male mice with aversive odor exposure; Statistical analysis was performed using one-way ANOVA and Bonferroni post hoc tests were applied for pairwaise comparisons. As in case of La data the assumption of homogeneity of variance is violated (S1 Table), Welch`s ANOVA was applied and followed by Games-Howell post hoc tests. ** p ≤ 0.01, * p ≤ 0.05, # p ≤ 0.1. (D,F,H): Data points represent c-Fos-ir cell density and SS/RS. correlations are significant in the lateral (D) and in the basolateral (F), but not in the central nucleus (H) of the amygdala.

Positive correlation of the density of c-Fos-immunoreactive cells and perfusion level changes points to an important relationship between perfusion and neuronal activity

Analyzing possible correlations between percental increase of perfusion from RS to SS (SS/RS perfusion level) and c-Fos-ir cell density in the amygdala resulted in a moderate, positive correlation, which was significant for La (r(13) = 0.630, p = 0.021; Fig 4D), BL (r(13) = 0.798, p = 0.001; Fig 4F) and Ce (r(13) = 0.583, p = 0.037; Fig 4H). Moreover, PS/RS perfusion correlated significantly with c-Fos-ir cell density in all three amygdala subnuclei (La: r(13) = 0.594, p = 0.032, BL: r(13) = 0.695, p = 0.008, Ce: r(13) = 0.587, p = 0.035).

Estrous cycle stage determination

The four different estrous cycle stages (proestrus, estrus, metestrus, diestrus) were fairly equally distributed across genotypes (χ2(6) = 5.527, p = 0.478; n = 28; S2 Table). Overall, however, the proestrus stage greatly predominated over the other stages (χ2(3) = 20.571, p<0.001; S2 Table). Given the significant distributional difference between estrous cycle stages (irrespective of the 5-Htt-genotype) and the fact that proestrus female mice (with overall highest estrogen levels) are less anxious than females in the other estrous phases [67], mice were classified into two groups (proestrus vs. other stages) for subsequent analyses.

Estrous cycle stage affects odor-induced perfusion level in the amygdala of female mice

Statistical results are summarized in S3 Table. Three-way mixed ANOVA on amygdala perfusion in female mice yielded a strong main effect of phase (F(2,44) = 26.388, p<0.0001) along with a phase x estrous cycle interaction (F(2,44) = 5.367, p = 0.009). Neither RS nor PS perfusion differed among estrous cycle groups (F(1,22) = 0.025, p = 0.876 and F(1,22) = 0.072, p = 0.791, respectively), while SS perfusion was significantly diminished in proestrus females relative to mice in other estrous stages (F(1,22) = 6.044, p = 0.022) (Fig 5A). This effect could be explained by a stronger increase in amygdala perfusion during odor exposure (RS→SS) in non-proestrus mice (p<0.0001) as compared to proestrus mice (p = 0.002). Furthermore, PS perfusion decreased significantly from SS levels (SS→PS) in non-proestrus females (p = 0.026) but remained elevated in proestrus mice (p = 1) (Fig 5A). Accordingly, when amygdala perfusion levels of the distinct fMRI phases were expressed as a fraction of one another (SS/RS, PS/RS, PS/SS), two-way ANOVA yielded the expected estrous cycle effect on SS/RS (F(1,22) = 6.978, p = 0.015; proestrus<other stages) (Fig 5C) and PS/SS (F(1,22) = 8.358, p = 0.008; proestrus>other stages) (Fig 5D) but not on PS/RS (F(1,22) = 0.045, p = 0.835). Similar results were obtained for whole-brain perfusion, though the effects were much less pronounced. Contrary to males, 5-Htt genotype exerted no significant effects in females, neither on RS perfusion nor on rat odor-induced perfusion level changes in both ROIs (Amygdala: Fig 5B, whole brain: S2 Fig).

Fig 5. CBF perfusion levels in the amygdala of female mice are affected by the estrous cycle stage but not by 5-Htt genotype.

Fig 5

A: Amygdala perfusion levels during resting state (RS), stimulation state (SS) and post-stimulation state (PS) depending on the estrous stage of female mice receiving an aversive odor during SS. Data represent mean perfusion level ± SEM; Statistical analysis was performed using three-way mixed ANOVA with genotype (5-Htt+/+, 5-Htt+/-, 5-Htt-/-) and estrous cycle group (non-proestrus vs. proestrus) as between-subjects factors and phase (RS, SS, PS) as within-subjects factor. Bonferroni post hoc tests were used for pairwise comparisons. *** p < 0.001, ** p ≤ 0.01, * p ≤ 0.05. Grey rectangle indicates significantly diminished SS perfusion levels of mice in proestrus compared to mice in other estrous stages. B: Cerebral perfusion levels during RS, SS and PS in the amygdala of female mice of all three 5-Htt genotypes depending on estrus stage. Data represent mean perfusion level ± SEM. (C, D): Data points represent individual and mean percental increase ± SEM in amygdala CBF levels in female mice depending on estrus stage from RS to SS (C) and SS to PS (D); Statistical analysis using three-way ANOVA and Bonferroni post hoc tests. * p ≤ 0.05, # p ≤ 0.1.

Finally, neither the genotype x estrous cycle interaction nor the interaction between these two factors and phase on both whole-brain and local amygdala perfusion levels were statistically significant, thereby demonstrating that the observed estrous cycle effects on stimulus-induced perfusion changes were comparable across 5-Htt genotypes (S3 Table).

The number of c-Fos-ir cells in the amygdala of females appear to be highest in 5-HTT +/+ animals (S3 Fig). However, due to the small sample size of investigated females (n = 6) and the potential influence of their estrous cycle stage it is impossible to draw any valid conclusions.

Discussion

We applied a CASL method of non-invasive ultra-high field perfusion MRI to analyse baseline perfusion levels and perfusion level changes in response to aversive odor in a coronal plane containing the amygdala, the predominant region for fear processing. We analysed female as well as male mice of all three 5-Htt genotypes. Subsequently performed c-Fos immunohistochemistry study served to demonstrate activation at cellular level.

Since the odor of rats is known to evoke fear in mice [35,36,38,39,6870], and that predator odors evoke an increase in c-Fos expression levels in different amygdala nuclei (as demonstrated by increased number of c-Fos-positive cells [4042], we assumed that a higher amygdala activation may become apparent after the presentation of the odor of rat soiled bedding as an aversive stimulus, even if the mice were under anesthetic. Previous work has shown the capability of several aversive odors including predator urine volatiles to evoke responses in the brain of anesthetized mice [7174]. As in our study in all experimental animals amygdala and total brain perfusion levels increased from RS to SS this assumption seemed to be right. Furthermore, as we detected more c-Fos-ir cells in the amygdala of mice exposed to the aversive rat odor than in mice exposed to neutral odor, what we show qualitatively, we conclude that rat odor is experienced as aversive by anaesthetized mice during fMRI. We assume that in association with the general perfusion increase the applied aversive rat odor represents a scent experience of special quality resulting in sustained activation of neurons. This is represented by the long-lasting high perfusion levels in male mice of all three 5-Htt genotypes even after termination of aversive odor presentation as well as by an increased amount of c-Fos-ir cells.

An influence of 5-Htt genotype on amygdala perfusion was revealed exclusively in male animals, with 5-HTT+/- mice exhibiting significantly higher RS perfusion levels compared to 5-HTT+/+ animals. In previous human studies also applying the CASL-method S-allele carriers, which may be best comparable to 5-HTT+/- mice with lower, but not completely absent 5-HTT protein levels, were shown to have an increased RS CBF compared to L-allele carriers (best comparable to 5-HTT+/+ mice) in the amygdala, but not in global brain [46,47]. These human studies revealed RS perfusion differences analyzing probands of both sexes. As, in contrast, Viviani and coworkers did not reveal an association between the 5-HTTLPR polymorphism and baseline brain perfusion in a cohort of healthy individuals applying CASL [48], we think that our study is of importance.

While mice of all three 5-Htt genotypes reached approximately the same perfusion levels during SS and PS, male 5-HTT+/+ mice showed a significantly higher percental perfusion level change from RS to SS (and PS) than 5-HTT+/- and 5-HTT-/- mice. These findings correspond to the increased density of c-Fos-ir cells in 5-HTT+/+ mice compared to 5-HTT+/- and -/- mice in all three amygdaloid nuclei. Correlation analysis provided evidence for a relationship of c-Fos-ir cell densities with perfusion level changes from RS to SS (and with a bit weaker significance from RS to PS). For a comprehensive interpretation of these correlation results one has to consider that the transcription factor c-Fos is shown to be differently regulated in individual brain regions, is discussed to be differently regulated in inhibitory and excitatory neurons, and that the time course of the induction and decay of Fos depends on the kind and strength of the stimulus itself [45,75,76]. Some brain regions seem to express no c-Fos at all despite various treatments [44]. Since the significance levels of our correlation analyses are not very different between Ce, a region with a high density of inhibitory neurons, and La, a region with a lower density of inhibitory neurons, we assume that the results of these correlation analyses do not reflect the type and composition of the amygdaloid nuclei analyzed. Therefore, there is currently no reason to doubt the validity of a positive correlation between c-Fos-positive cells and SS/RS perfusion. However, since the use of transcription inhibitors can block long-term synaptic plasticity [77], which is associated with changes in the expression of IEGs and their downstream genes, it would make sense to investigate in a future experiment whether the use of transcription inhibitors is able to reduce changes in perfusion levels from RS to SS shown in this study. This would highlight the physiological nature of c-Fos induction in relation to blood flow changes.

These lower perfusion level changes from RS to SS/PS in 5-HTT-/- and 5-HTT+/- mice than in 5-HTT+/+ controls are reminiscent of findings concerning stress-induced variations in the spine density of BLA pyramidal neurons, a morphological correlate of amygdala neuronal excitability, in male 5-HTT+/+ and 5-HTT-/- mice [78]. The fact that under basal conditions spine density in 5-HTT+/+ mice was significantly lower than in 5-HTT-/- mice, and stress experience induced spinogenesis in 5-HTT+/+ to the level of non-stressed 5-HTT-/- mice but failed to further increase spine density in 5-HTT-/- mice, can be interpreted as a “ceiling” effect. Diminished increase in amygdala perfusion upon predator odor and lack of stress-induced spinogenesis in 5-HTT-deficient mice suggest a dysfunction of neuroadaptive mechanisms that are meant to enable coping with aversive stimuli and also supports the “tonic model” of 5-HTTLPR function first suggested by Canli and Lesch in 2007 [5].

In contrast to the results with using males, females miss a clear effect of the 5-Htt genotype on the level of amygdala perfusion.

Female mice were shown to be in different estrous stages during the experiment. Although the group size of particular estrous stage groups was rather small, a significant interaction between estrous stage and fMRI phase became statistically discernable in whole brain perfusion measurements, which was even stronger in amygdala measurements. Proestrus females (with high estrogen/progesterone levels) showed a lower increase in perfusion during odor exposure relative to non-proestrus mice. As several studies demonstrated that females in the high-estrogen proestrus phase exhibited low anxiety-levels [67], less fear and a stronger fear extinction [79,80], as well as reduced neural activity in the bed nucleus of stria terminalis in response to an innate fear-inducing stimulus than females in low-estrogen phases [81] we can assume that the low SS perfusion levels we detected in our proestrous-staged mice indicate low anxiety levels of these mice.

Furthermore, PS perfusion levels did not differ significantly from SS levels in male mice (irrespective of the 5-Htt genotype). This missing reduction of CBF during PS in male mice could be the result of a long-lasting elevation of extracellular 5-HT levels after fearful experiences, reaching their maximum approximately 30–40 min after stimulus presentation with only a slow decrease to baseline levels [82,83]. Long-lasting high extracellular 5-HT levels in the amygdala could keep them in an activated status. In order to reveal a decrease of perfusion levels during PS an extension of CBF measurement during this fMRI state would be helpful.

In contrast to the results with male mice, in (low-estrogen) non-proestrus female mice PS perfusion levels decreased significantly from SS, but remained elevated like in male animals in (high-estrogen) proestrus females. Beside the variability and the influence of the estrous stage within the female group, the sex-specific processing of social cues could explain the differences between the results of both sexes. Male and female mice differently respond to the same stimuli presumably resulting in contrary behavioral output [84,85]. In general, obvious sex differences in rodents exist that influence 5-HT modulation in the amygdala, potentially derived from differential 5-HT receptor expression [86], varying 5-HT levels, extracellular [87] as well as in amygdala tissue extracts [88], both in neutral and stressful conditions. In summary, these obvious differences between males and females point to sex differences in fear processing in which the amygdala is involved.

Interestingly, the density of c-Fos-ir cells was ten times higher in the Ce compared to the La and BL in male as well as in female mice independent of their 5-Htt genotype. The Ce, which is–in contrast to the BLA with appr. 80% glutamatergic neurons—mainly comprised of GABAergic neurons, forms connections to brain areas, including the periaqueductal grey [89,90], that mediate defensive behaviors and regulate fear responses [23]. Vice versa 5-HT fibres in the La, BL and Ce mainly orginate in dorsal raphe neurons (DRNs) [25,27,9193], a part of the periaqueductal grey, and sparsely from median raphe neurons [26,27,29]. These 5-HT innervations originating in DRNs are known to modulate the amygdaloid microcircuitry encoding the fear response after negative stimuli. Assuming that 5-HTT+/+ mice display lower and 5-HTT-/- mice higher fear and anxiety-like behaviors, the critical role of the 5-HTT in the underlying mechanisms is undoubted.

As in all three amygaloid nuclei c-Fos-ir cell densities post mortem (but also percental perfusion change from RS to SS during MRI) were significantly increased in 5-HTT+/+ compared to 5-HTT+/- and 5-HTT-/- mice the question for the cell type responsible for this increased amygdala activation emerges, e.g. the ratio between c-Fos-positive glutamatergic and GABAergic cells in the BLA would be of great interest. Presumably, 5-Htt-genotype dependent alterations in the local inhibitory circuits with consequences on the amygdaloid output could be one approach to explain behavioral differences between mice of various 5-Htt-genotypes [15,17,18,94].

In contrast to the results of our mouse fMRI study, it was reported that human S-allele carriers show amygdala hyperreactivity in response to the presentation of angry and fearful faces [4955] suggesting 5-HTTLPR-dependent differences in face processing [9599]. Therefore, our results of exaggerated increase of CBF levels from RS to SS in 5-HTT+/+ mice, and not in 5-HTT+/- and -/- mice, seem at first to be contradictory. However, this exaggerated increase of CBF levels from RS to SS in 5-HTT+/+ mice, and not in 5-HTT+/- and -/- mice, is supported by the tonic activation model of 5-HTTLPR function suggested by Canli and coworkers [46,51], for review: [5]), but not by the standard phasic activation model of 5-HTTLPR function. Tonic firing of 5-HT neuron population activity seems related to the extra-synaptic tonic 5-HT levels and phasic firing activity to the rapid, high-amplitude, and intra-synaptic 5-HT release.The tonic model assumes lower RS baseline perfusion levels for LL-allele carriers relative to S-allele carriers. Perfusion imaging data obtained by Canli and coworkers exactly confirmed this assumption of elevated baseline amygdala activation levels of 5-HTTLPR S-allele carriers compared with LL-allele carriers [46], and fit to the results of this study. However, this does not preclude the amygdala of S-allele carriers from reacting to stress with a strong phasic response on top of its elevated baseline levels [5]. Moreover, a ceiling effect is suggested as the maximal activation level observed in the amygdala during the SS condition is not different between mice of all three 5-Htt genotypes. Therefore, it is necessary that the change from RS to that ceiling (SS) level is much larger for 5-HTT+/+ than for 5-HTT+/- mice, as they start from a lower resting baseline.

Beyond that, several differences of the human and rodent study designs, e.g. different natures of stimuli and different techniques and ways of analysis, have to be taken into account, which renders direct comparisons difficult. Different natures of stimuli are processed through different networks including the amygdala, and the role of the amygdala seems to be different in either case. During face processing the amygdala is triggering gaze changes towards diagnostically relevant facial features, which is shown to be modulated by the 5-HTTLPR [97]. In contrast, in our study the role of the amygdala is in the processing of the threatening odor of a predator. Regarding different methodologies, BOLD-contrast imaging in human studies enables a time-related resolution of seconds [100]. In our study we applied a CASL method [57] similar to the ASL method Canli and coworkers applied in her human study from 2006 [46]. Based on our setup and parameters, the particular measurements for RS, SS and PS lasted 20–30 min, with the scope of long-term perfusion levels and long-term effects of stimulations.

To our knowledge, we were the first to show a correlation between the signal change of perfusion levels in a brain region and the density of c-Fos-ir cells in the same region post mortem. This suggests that the perfusion level increase in a distinct brain region derives from an accumulation of cell populations being activated, supporting the use of c-Fos-detection as a marker for neuronal activity. Moreover, the present study contributes to the findings that the 5-Htt/5-HTT genotype modulates fear and anxiety-like behaviors after aversive stimuli by means of differential activation of the amygdala, at least in male mice. Furthermore, we were the first demonstrating sex differences in amygdala perfusion levels after the exposure to an aversive rat odor, and that estrous levels seem to have a tremendous influence on the activity of the amygdala. Last but not least, we provide an important contribution to the controversial discussion on the topic “phasic and/or tonic model of 5-HTTLPR function” in the human imaging literature. Nevertheless, our results support the notion that fMRI investigations are an appropriate tool to study brain activation patterns in the field of fear and anxiety research, but also in other research fields.

Supporting information

S1 Fig. Cerebral perfusion levels in whole brain of male mice are not influenced by the 5-Htt genotype.

Cerebral perfusion levels during resting state (RS), stimulation state (SS) and post-stimulation state (PS) in whole brain of male mice of all three 5-Htt genotypes. Data represent mean perfusion level ± SEM.

(TIF)

S2 Fig. Cerebral perfusion levels in whole brain of female (B) mice are not influenced by the 5-Htt genotype.

Cerebral perfusion levels during different fMRI states in whole brain of female mice of all three 5-Htt genotypes depending on their estrous stage receiving an aversive odor during SS. Data represent mean perfusion level ± SEM.

(TIF)

S3 Fig. Density of c-Fos-immunoreactive cells in the investigated amygdaloid nuclei with aversive odor presentation during fMRI experiment.

(A, B, C): Individual and mean density of c-Fos-immunoreactive cells (number of c-Fos-ir cells per μm2) in the lateral, basolateral and central amygdaloid nucleus of female mice with aversive rat odor exposure.

(TIF)

S1 Table. Descriptive and inferential statistics of fMRI measurements with male mice of different 5-Htt genotypes.

(DOCX)

S2 Table. Estrous cycle staging in female mice.

(DOCX)

S3 Table. Descriptive and inferential statistics of fMRI measurements with female mice of different 5-Htt genotypes.

(DOCX)

Acknowledgments

Special thanks go to Sabine Voll, Marion Winnig, and Eva-Kristin Broschk for excellent technical assistance.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This work was funded by the German Research Foundation (DFG; https://www.dfg.de/), grant number 44541416: Collaborative Research Centre/Transregio 58 (CRC-TRR58), subproject A1 to KPL and subproject A5 to KPL and ASB. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.

References

  • 1.Lesch KP, Gutknecht L. Pharmacogenetics of the serotonin transporter. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29: 1062–73. 10.1016/j.pnpbp.2005.03.012 [DOI] [PubMed] [Google Scholar]
  • 2.Kugaya A, Seneca NM, Snyder PJ, Williams SA, Malison RT, Baldwin RM, et al. Changes in humanin vivoserotonin and dopamine transporter availabilities during chronic antidepressantadministration. Neuropsychopharmacology. 2003;28: 413–420. 10.1038/sj.npp.1300036 [DOI] [PubMed] [Google Scholar]
  • 3.Olivier JDA, Vinkers CH, Olivier B. The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders. Frontiers in Pharmacology. Frontiers Media SA; 2013. p. 74 10.3389/fphar.2013.00074 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Lesch K-P, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274: 1527–1531. 10.1126/science.274.5292.1527 [DOI] [PubMed] [Google Scholar]
  • 5.Canli T, Lesch K-P. Long story short: the serotonin transporter in emotion regulation and social cognition. Nat Neurosci. 2007;10: 1103–9. 10.1038/nn1964 [DOI] [PubMed] [Google Scholar]
  • 6.Homberg JR, Lesch K-P. Looking on the bright side of serotonin transporter gene variation. Biol Psychiatry. 2011;69: 513–9. 10.1016/j.biopsych.2010.09.024 [DOI] [PubMed] [Google Scholar]
  • 7.Homberg JR, Schubert D, Asan E, Aron EN. Sensory processing sensitivity and serotonin gene variance: Insights into mechanisms shaping environmental sensitivity. Neuroscience and Biobehavioral Reviews. 2016. pp. 472–483. 10.1016/j.neubiorev.2016.09.029 [DOI] [PubMed] [Google Scholar]
  • 8.Hu X-Z, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet. 2006;78: 815–26. 10.1086/503850 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, et al. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine (“Ecstasy”) in serotonin transporter-deficient mice. Mol Pharmacol. 1998;53: 649–55. 10.1124/mol.53.4.649 [DOI] [PubMed] [Google Scholar]
  • 10.Gobbi G, Murphy D, Lesch K, Blier P. Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study. J Pharmacol. 2001;296: 987–995. [PubMed] [Google Scholar]
  • 11.Li Q, Wichems CH, Ma L, Van de Kar LD, Garcia F, Murphy DL. Brain region-specific alterations of 5-HT2A and 5-HT2C receptors in serotonin transporter knockout mice. J Neurochem. 2003;84: 1256–1265. 10.1046/j.1471-4159.2003.01607.x [DOI] [PubMed] [Google Scholar]
  • 12.Fabre V, Beaufour C, Evrard A, Rioux A, Hanoun N, Lesch KP, et al. Altered expression and functions of serotonin 5-HT 1A and 5-HT 1B receptors in knock-out mice lacking the 5-HT transporter. Neuroscience. 2000;12: 2299–2310. Available: http://www.molecularpsychiatry.uk-wuerzburg.de/fileadmin/uk/molecularpsychiatry/PDFs/2000/Fabreetal.00.pdf. [DOI] [PubMed] [Google Scholar]
  • 13.Shen HW, Hagino Y, Kobayashi K, Shinohara-Tanaka K, Ikeda K, Yamamoto H, et al. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology. 2004;29: 1790–1799. 10.1038/sj.npp.1300476 [DOI] [PubMed] [Google Scholar]
  • 14.Mathews TA, Fedele DE, Coppelli FM, Avila AM, Murphy DL, Andrews AM. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression Journal of Neuroscience Methods. Elsevier; 2004. pp. 169–181. 10.1016/j.jneumeth.2004.05.017 [DOI] [PubMed] [Google Scholar]
  • 15.Holmes A, Li Q, Murphy DL, Gold E, Crawley JN. Abnormal anxiety-related behaviour in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav. 2003;2: 365–380. 10.1046/j.1601-1848.2003.00050.x [DOI] [PubMed] [Google Scholar]
  • 16.Holmes A, Yang RJ, Lesch K-P, Crawley JN, Murphy DL. Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology. 2003;28: 2077–2088. 10.1038/sj.npp.1300266 [DOI] [PubMed] [Google Scholar]
  • 17.Murphy DL, Lesch KP. Targeting the murine serotonin transporter: Insights into human neurobiology. Nature Reviews Neuroscience. 2008. pp. 85–96. 10.1038/nrn2284 [DOI] [PubMed] [Google Scholar]
  • 18.Karabeg MM, Grauthoff S, Kollert SY, Weidner M, Heiming RS, Jansen F, et al. 5-HTT deficiency affects neuroplasticity and increases stress sensitivity resulting in altered spatial learning performance in the Morris water maze but not in the Barnes maze. PLoS One. 2013;8: e78238 10.1371/journal.pone.0078238 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Carroll JC, Boyce-Rustay JM, Millstein R, Yang R, Wiedholz LM, Murphy DL, et al. Effects of mild early life stress on abnormal emotion-related behaviors in 5-HTT knockout mice. Behav Genet. 2007;37: 214–222. 10.1007/s10519-006-9129-9 [DOI] [PubMed] [Google Scholar]
  • 20.Heiming RS, Sachser N. Consequences of serotonin transporter genotype and early adversity on behavioral profile—pathology or adaptation? Frontiers in Neuroscience. 2010. 10.3389/fnins.2010.00187 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Bodden C, Richter SH, Schreiber RS, Kloke V, Gerß J, Palme R, et al. Benefits of adversity?! How life history affects the behavioral profile of mice varying in serotonin transporter genotype. Front Behav Neurosci. 2015;9: 47 10.3389/fnbeh.2015.00047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Adamec R, Burton P, Blundell J, Murphy DL, Holmes A. Vulnerability to mild predator stress in serotonin transporter knockout mice. Behav Brain Res. 2006;170: 126–140. 10.1016/j.bbr.2006.02.012 [DOI] [PubMed] [Google Scholar]
  • 23.Tovote P, Fadok JP, Luthi A. Neuronal circuits for fear and anxiety. Nat Rev Neurosci. 2015;16: 317–331. 10.1038/nrn3945 [DOI] [PubMed] [Google Scholar]
  • 24.Dogra N, Lunn B, Cooper S. Psychiatry by ten teachers, second edition Psychiatry by Ten Teachers, Second Edition Nature Publishing Group; 2017. 10.1201/9781315380612 [DOI] [Google Scholar]
  • 25.Vertes RP. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J Comp Neurol. 1991;313: 643–668. 10.1002/cne.903130409 [DOI] [PubMed] [Google Scholar]
  • 26.Vertes RP, Fortin WJ, Crane AM. Projections of the median raphe nucleus in the rat. J Comp Neurol. 1999;407: 555–582. [DOI] [PubMed] [Google Scholar]
  • 27.Muzerelle A, Scotto-Lomassese S, Bernard JF, Soiza-Reilly M, Gaspar P. Conditional anterograde tracing reveals distinct targeting of individual serotonin cell groups (B5–B9) to the forebrain and brainstem. Brain Struct Funct. 2016;221: 535–561. 10.1007/s00429-014-0924-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.McDonald AJ. Neurons of the Lateral and Basolateral Amygdaloid Nuclei: A Golgi Study in the Rat. J Comp Neurol. 1982;312: 293–312. 10.1002/cne.902120307 [DOI] [PubMed] [Google Scholar]
  • 29.Asan E, Steinke M, Lesch KP. Serotonergic innervation of the amygdala: Targets, receptors, and implications for stress and anxiety. Histochemistry and Cell Biology. 2013. pp. 785–813. 10.1007/s00418-013-1081-1 [DOI] [PubMed] [Google Scholar]
  • 30.Stowers L, Logan DW. Olfactory mechanisms of stereotyped behavior: on the scent of specialized circuits. Current Opinion in Neurobiology. 2010. pp. 274–280. 10.1016/j.conb.2010.02.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Root CM, Denny CA, Hen R, Axel R. The participation of cortical amygdala in innate, odour-driven behaviour. Nature. 2014;515: 269–273. 10.1038/nature13897 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Thompson JA, Salcedo E, Restrepo D, Finger TE. Second-order input to the medial amygdala from olfactory sensory neurons expressing the transduction channel TRPM5. J Comp Neurol. 2012;520: 1819–1830. 10.1002/cne.23015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Keshavarzi S, Power JM, Albers EHH, Sullivan RKS, Sah P. Dendritic Organization of Olfactory Inputs to Medial Amygdala Neurons. J Neurosci. 2015;35: 13020–13028. 10.1523/JNEUROSCI.0627-15.2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Brennan PA, Zufall F. Pheromonal communication in vertebrates. Nature. 2006;444: 308–315. 10.1038/nature05404 [DOI] [PubMed] [Google Scholar]
  • 35.Calvo-Torrent A, Brain PF, Martinez M. Effect of predatory stress on sucrose intake and behavior on the plus-maze in male mice. Physiol Behav. 1999;67: 189–196. 10.1016/s0031-9384(99)00051-7 [DOI] [PubMed] [Google Scholar]
  • 36.Yang M, Augustsson H, Markham CM, Hubbard DT, Webster D, Wall PM, et al. The rat exposure test: A model of mouse defensive behaviors. Physiol Behav. 2004;81: 465–473. 10.1016/j.physbeh.2004.02.010 [DOI] [PubMed] [Google Scholar]
  • 37.Apfelbach R, Blanchard CD, Blanchard RJ, Hayes RA, McGregor IS. The effects of predator odors in mammalian prey species: A review of field and laboratory studies Neuroscience and Biobehavioral Reviews. Pergamon; 2005. pp. 1123–1144. 10.1016/j.neubiorev.2005.05.005 [DOI] [PubMed] [Google Scholar]
  • 38.Banik A, Anand A. Loss of learning in mice when exposed to rat odor: A water maze study. Behav Brain Res. 2011;216: 466–471. 10.1016/j.bbr.2010.07.035 [DOI] [PubMed] [Google Scholar]
  • 39.Campos KFC, Amaral VCS, Rico JL, Miguel TT, Nunes-de-Souza RL. Ethopharmacological evaluation of the rat exposure test: A prey-predator interaction test. Behav Brain Res. 2013;240: 160–170. 10.1016/j.bbr.2012.11.023 [DOI] [PubMed] [Google Scholar]
  • 40.Asok A, Ayers LW, Awoyemi B, Schulkin J, Rosen JB. Immediate early gene and neuropeptide expression following exposure to the predator odor 2,5-dihydro-2,4,5-trimethylthiazoline (TMT). Behav Brain Res. 2013;248: 85–93. 10.1016/j.bbr.2013.03.047 [DOI] [PubMed] [Google Scholar]
  • 41.Sotnikov S V., Chekmareva NY, Schmid B, Harbich D, Malik V, Bauer S, et al. Enriched environment impacts trimethylthiazoline-induced anxiety-related behavior and immediate early gene expression: Critical role of Crhr1. Eur J Neurosci. 2014;40: 2691–2700. 10.1111/ejn.12624 [DOI] [PubMed] [Google Scholar]
  • 42.Weera MM, Schreiber AL, Avegno EM, Gilpin NW. The role of central amygdala corticotropin-releasing factor in predator odor stress-induced avoidance behavior and escalated alcohol drinking in rats. Neuropharmacology. 2020;166: 107979 10.1016/j.neuropharm.2020.107979 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Schwartz WJ, Smith CB, Davidsen L, Savaki H, Sokoloff L, Mata M, et al. Metabolic mapping of functional activity in the hypothalamo- neurohypophysial system of the rat. Science (80-). 1979;205: 723–725. 10.1126/science.462184 [DOI] [PubMed] [Google Scholar]
  • 44.Dragunow M, Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods. 1989;29: 261–265. 10.1016/0165-0270(89)90150-7 [DOI] [PubMed] [Google Scholar]
  • 45.Kovács KJ. Measurement of Immediate-Early Gene Activation- c-fos and Beyond. J Neuroendocrinol. 2008;20: 665–672. 10.1111/j.1365-2826.2008.01734.x [DOI] [PubMed] [Google Scholar]
  • 46.Canli T, Qiu M, Omura K, Congdon E, Haas BW, Amin Z, et al. Neural correlates of epigenesis. Proc Natl Acad Sci. 2006;103: 16033–16038. 10.1073/pnas.0601674103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Rao H, Gillihan SJ, Wang J, Korczykowski M, Sankoorikal GM V, Kaercher KA, et al. Genetic variation in serotonin transporter alters resting brain function in healthy individuals. Biol Psychiatry. 2007;62: 600–6. 10.1016/j.biopsych.2006.11.028 [DOI] [PubMed] [Google Scholar]
  • 48.Viviani R, Sim EJ, Lo H, Beschoner P, Osterfeld N, Maier C, et al. Baseline Brain Perfusion and the Serotonin Transporter Promoter Polymorphism. Biol Psychiatry. 2010;67: 317–322. 10.1016/j.biopsych.2009.08.035 [DOI] [PubMed] [Google Scholar]
  • 49.Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, et al. Serotonin transporter genetic variation and the response of the human amygdala. Science. 2002;297: 400–3. 10.1126/science.1071829 [DOI] [PubMed] [Google Scholar]
  • 50.Hariri AR, Drabant EM, Munoz KE, Kolachana BS, Mattay VS, Egan MF, et al. A Susceptibility Gene for Affective Disorders and the Response of the Human Amygdala. Arch Gen Psychiatry. 2005;62: 146 10.1001/archpsyc.62.2.146 [DOI] [PubMed] [Google Scholar]
  • 51.Canli T, Omura K, Haas BW, Fallgatter A, Constable RT, Lesch KP. Beyond affect: A role for genetic variation of the serotonin transporter in neural activation during a cognitive attention task. Proc Natl Acad Sci. 2005;102: 12224–12229. 10.1073/pnas.0503880102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Munafò MR, Brown SM, Hariri AR. Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol Psychiatry. 2008;63: 852–7. 10.1016/j.biopsych.2007.08.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Heinz A, Smolka MN, Braus DF, Wrase J, Beck A, Flor H, et al. Serotonin transporter genotype (5-HTTLPR): effects of neutral and undefined conditions on amygdala activation. Biol Psychiatry. 2007;61: 1011–4. 10.1016/j.biopsych.2006.08.019 [DOI] [PubMed] [Google Scholar]
  • 54.Hariri AR, Holmes A. Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn Sci. 2006;10: 182–91. 10.1016/j.tics.2006.02.011 [DOI] [PubMed] [Google Scholar]
  • 55.Hariri AR, Drabant EM, Weinberger DR. Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing. Biol Psychiatry. 2006;59: 888–97. 10.1016/j.biopsych.2005.11.005 [DOI] [PubMed] [Google Scholar]
  • 56.Brockmann H, Zobel A, Schuhmacher A, Daamen M, Joe A, Biermann K, et al. Influence of 5-HTTLPR polymorphism on resting state perfusion in patients with major depression. J Psychiatr Res. 2011;45: 442–451. 10.1016/j.jpsychires.2010.08.016 [DOI] [PubMed] [Google Scholar]
  • 57.Alsop D, Detre J. Perfusion magnetic resonance imaging with continuous arterial spin labeling: methods and clinical applications in the central nervous system. Eur J Radiol. 1999;30: 115–124. 10.1016/s0720-048x(99)00050-9 [DOI] [PubMed] [Google Scholar]
  • 58.McLean AC, Valenzuela N, Fai S, Bennett SAL. Performing Vaginal Lavage, Crystal Violet Staining, and Vaginal Cytological Evaluation for Mouse Estrous Cycle Staging Identification. J Vis Exp. 2012 [cited 13 Jan 2018]. 10.3791/4389 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Detre JA, Leigh JS, Williams DS, Koretsky AP. Perfusion imaging. Magn Reson Med. 1992;23: 37–45. 10.1002/mrm.1910230106 [DOI] [PubMed] [Google Scholar]
  • 60.Williams DS, Detre JA, Leigh JS, Koretsky AP. Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci U S A. 1992;89: 212–6. 10.1073/pnas.89.1.212 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Wong EC, Buxton RB, Frank LR. A theoretical and experimental comparison of continuous and pulsed arterial spin labeling techniques for quantitative perfusion imaging. Magn Reson Med. 1998;40: 348–355. 10.1002/mrm.1910400303 [DOI] [PubMed] [Google Scholar]
  • 62.Pham M, Helluy X, Braeuninger S, Jakob P, Stoll G, Kleinschnitz C, et al. Outcome of experimental stroke in C57Bl/6 and Sv/129 mice assessed by multimodal ultra-high field MRI. Exp Transl Stroke Med. 2010;2: 6 10.1186/2040-7378-2-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Pham M, Helluy X, Kleinschnitz C, Kraft P, Bartsch AJ, Jakob P, et al. Sustained reperfusion after blockade of glycoprotein-receptor-IB in focal cerebral ischemia: An MRI study at 17.6 Tesla. PLoS One. 2011;6 10.1371/journal.pone.0018386 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Watson C, Paxinos G. Paxinos and Franklin’s the Mouse Brain in Stereotaxic Coordinates, Fourth Edition The Spinal Cord: A Christopher and Dana Reeve Foundation Text and Atlas; 2012. [Google Scholar]
  • 65.Periaswamy S, Farid H. Elastic Registration with Partial Data Biomedical Image Registration. Springer, Berlin, Heidelberg; 2003. pp. 102–111. 10.1007/978-3-540-39701-4_11 [DOI] [Google Scholar]
  • 66.Periaswamy S, Farid H. Medical image registration with partial data. Med Image Anal. 2006;10: 452–464. 10.1016/j.media.2005.03.006 [DOI] [PubMed] [Google Scholar]
  • 67.Walf AA, Koonce C, Manley K, Frye CA. Proestrous compared to diestrous wildtype, but not estrogen receptor beta knockout, mice have better performance in the spontaneous alternation and object recognition tasks and reduced anxiety-like behavior in the elevated plus and mirror maze. Behav Brain Res. 2009;196: 254–260. 10.1016/j.bbr.2008.09.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Molina V, Ciesielski L, Gobaille S, Isel F, Mandel P. Inhibition of mouse killing behavior by serotonin-mimetic drugs: Effects of partial alterations of serotonin neurotransmission. Pharmacol Biochem Behav. 1987;27: 123–131. 10.1016/0091-3057(87)90486-2 [DOI] [PubMed] [Google Scholar]
  • 69.Huo Y, Fang Q, Shi Y-L, Zhang Y-H, Zhang J-X. Chronic exposure to a predator or its scent does not inhibit male-male competition in male mice lacking brain serotonin. Front Behav Neurosci. 2014;8: 116 10.3389/fnbeh.2014.00116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Liu YJ, Li LF, Zhang YH, Guo HF, Xia M, Zhang MW, et al. Chronic Co-species Housing Mice and Rats Increased the Competitiveness of Male Mice. Chem Senses. 2017;42: 247–257. 10.1093/chemse/bjw164 [DOI] [PubMed] [Google Scholar]
  • 71.Stettler DD, Axel R. Representations of Odor in the Piriform Cortex. Neuron. 2009;63: 854–864. 10.1016/j.neuron.2009.09.005 [DOI] [PubMed] [Google Scholar]
  • 72.Kass MD, Rosenthal MC, Pottackal J, McGann JP. Fear learning enhances neural responses to threat-predictive sensory stimuli. Science (80-). 2013;342: 1389–1392. 10.1126/science.1244916 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Dewan A, Pacifico R, Zhan R, Rinberg D, Bozza T. Non-redundant coding of aversive odours in the main olfactory pathway. Nature. 2013;497: 486–489. 10.1038/nature12114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Ross JM, Fletcher ML. Olfactory fear conditioning non-specifically enhances glomerular odor responses and increases representational overlap of learned and neutral odors. 2017. [cited 12 Jan 2018]. 10.1101/194415 [DOI] [Google Scholar]
  • 75.Staiger JF, Masanneck C, Bisler S, Schleicher A, Zuschratter W, Zilles K. Excitatory and inhibitory neurons express c-Fos in barrel-related columns after exploration of a novel environment. Neuroscience. 2002;109: 687–699. 10.1016/s0306-4522(01)00501-2 [DOI] [PubMed] [Google Scholar]
  • 76.Robins MT, Li J, Ryabinin AE. Effects of Housing Conditions and Circadian Time on Baseline c-Fos Immunoreactivity in C57BL/6J Mice. Neuroscience. 2020;431: 143–151. 10.1016/j.neuroscience.2020.02.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Frey U, Frey S, Schollmeier F, Krug M. Influence of actinomycin D, a RNA synthesis inhibitor, on long-term potentiation in rat hippocampal neurons in vivo and in vitro. J Physiol. 1996;490: 703–711. 10.1113/jphysiol.1996.sp021179 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Nietzer SL, Bonn M, Jansen F, Heiming RS, Lewejohann L, Sachser N, et al. Serotonin transporter knockout and repeated social defeat stress: Impact on neuronal morphology and plasticity in limbic brain areas. Behav Brain Res. 2011;220: 42–54. 10.1016/j.bbr.2011.01.011 [DOI] [PubMed] [Google Scholar]
  • 79.Milad MR, Igoe SA, Lebron-Milad K, Novales JE. Estrous cycle phase and gonadal hormones influence conditioned fear extinction. Neuroscience. 2009;164: 887–895. 10.1016/j.neuroscience.2009.09.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Maeng LY, Cover KK, Landau AJ, Milad MR, Lebron-Milad K. Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats. J Vis Exp. 2015. [cited 13 Jan 2018]. 10.3791/52202 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Chen W, Shields J, Huang W, King JA. Female fear: Influence of estrus cycle on behavioral response and neuronal activation. Behav Brain Res. 2009;201: 8–13. 10.1016/j.bbr.2009.01.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Yokoyama M, Suzuki E, Sato T, Maruta S, Watanabe S, Miyaoka H. Amygdalic levels of dopamine and serotonin rise upon exposure to conditioned fear stress without elevation of glutamate. Neurosci Lett. 2005;379: 37–41. 10.1016/j.neulet.2004.12.047 [DOI] [PubMed] [Google Scholar]
  • 83.Zanoveli JM, Carvalho MC, Cunha JM, Brandão ML. Extracellular serotonin level in the basolateral nucleus of the amygdala and dorsal periaqueductal gray under unconditioned and conditioned fear states: An in vivo microdialysis study. Brain Res. 2009;1294: 106–115. 10.1016/j.brainres.2009.07.074 [DOI] [PubMed] [Google Scholar]
  • 84.Bergan JF, Ben-Shaul Y, Dulac C. Sex-specific processing of social cues in the medial amygdala. Elife. 2014;3: e02743 10.7554/eLife.02743 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Li Y, Dulac C. Neural coding of sex-specific social information in the mouse brain. Current Opinion in Neurobiology. 2018. pp. 120–130. 10.1016/j.conb.2018.07.005 [DOI] [PubMed] [Google Scholar]
  • 86.Zhang L, Ma W, Barker JL, Rubinow DR. SEX DIFFERENCES IN EXPRESSION OF SEROTONIN RECEPTORS (SUBTYPES 1A AND 2A) IN RAT BRAIN: A POSSIBLE ROLE OF TESTOSTERONE. Neuroscience. 1999;94: 251–259. 10.1016/s0306-4522(99)00234-1 [DOI] [PubMed] [Google Scholar]
  • 87.Mitsushima D, Yamada K, Takase K, Funabashi T, Kimura F. Sex differences in the basolateral amygdala: the extracellular levels of serotonin and dopamine, and their responses to restraint stress in rats. Eur J Neurosci. 2006;24: 3245–3254. 10.1111/j.1460-9568.2006.05214.x [DOI] [PubMed] [Google Scholar]
  • 88.Duchesne A, Dufresne MM, Sullivan RM. Sex differences in corticolimbic dopamine and serotonin systems in the rat and the effect of postnatal handling. Prog Neuro-Psychopharmacology Biol Psychiatry. 2009;33: 251–261. 10.1016/j.pnpbp.2008.11.012 [DOI] [PubMed] [Google Scholar]
  • 89.Johansen JP, Tarpley JW, Ledoux JE, Blair HT. Neural substrates for expectation-modulated fear learning in the amygdala and periaqueductal gray. Nat Neurosci. 2010;13: 979–986. 10.1038/nn.2594 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Tovote P, Esposito MS, Botta P, Chaudun F, Fadok JP, Markovic M, et al. Midbrain circuits for defensive behaviour. Nature. 2016;534: 206–212. 10.1038/nature17996 [DOI] [PubMed] [Google Scholar]
  • 91.Jacobs BL, Foote SL, Bloom FE. Differential projections of neurons within the dorsal raphe nucleus of the rat: a horseradish peroxidase (HRP) study. Brain Res. 1978;147: 149–153. 10.1016/0006-8993(78)90779-5 [DOI] [PubMed] [Google Scholar]
  • 92.Abrams JK, Johnson PL, Hollis JH, Lowry CA. Anatomic and functional topography of the dorsal raphe nucleus Annals of the New York Academy of Sciences. Blackwell Publishing Ltd; 2004. pp. 46–57. 10.1196/annals.1296.005 [DOI] [PubMed] [Google Scholar]
  • 93.Halberstadt AL, Balaban CD. Serotonergic and nonserotonergic neurons in the dorsal raphe nucleus send collateralized projections to both the vestibular nuclei and the central amygdaloid nucleus. Neuroscience. 2006;140: 1067–1077. 10.1016/j.neuroscience.2006.02.053 [DOI] [PubMed] [Google Scholar]
  • 94.Holmes A, Yang RJ, Lesch K-P, Crawley JN, Murphy DL. Mice Lacking the Serotonin Transporter Exhibit 5-HT1A Receptor-Mediated Abnormalities in Tests for Anxiety-like Behavior. Neuropsychopharmacology. 2003. [cited 6 Feb 2018]. 10.1038/sj.npp.1300266 [DOI] [PubMed] [Google Scholar]
  • 95.von dem Hagen EAH, Passamonti L, Nutland S, Sambrook J, Calder AJ. The serotonin transporter gene polymorphism and the effect of baseline on amygdala response to emotional faces. Neuropsychologia. 2011;49: 674–680. 10.1016/j.neuropsychologia.2010.12.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Koizumi A, Kitagawa N, Kondo HM, Kitamura MS, Sato T, Kashino M. Serotonin Transporter Gene-Linked Polymorphism Affects Detection of Facial Expressions. PLoS One. 2013;8 10.1371/journal.pone.0059074 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Boll S, Gamer M. 5-HTTLPR modulates the recognition accuracy and exploration of emotional facial expressions. Front Behav Neurosci. 2014;8: 255 10.3389/fnbeh.2014.00255 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Hildebrandt A, Kiy A, Reuter M, Sommer W, Wilhelm O. Face and emotion expression processing and the serotonin transporter polymorphism 5-HTTLPR/rs22531. Genes, Brain Behav. 2016;15: 453–464. 10.1111/gbb.12295 [DOI] [PubMed] [Google Scholar]
  • 99.Velasquez F, Wiggins JL, Mattson WI, Martin DM, Lord C, Monk CS. The influence of 5-HTTLPR transporter genotype on amygdala-subgenual anterior cingulate cortex connectivity in autism spectrum disorder. Dev Cogn Neurosci. 2017;24: 12–20. 10.1016/j.dcn.2016.12.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Hennig J, Speck O, Koch MA, Weiller C. Functional magnetic resonance imaging: A review of methodological aspects and clinical applications. J Magn Reson Imaging. 2003;18: 1–15. 10.1002/jmri.10330 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Tamas Kozicz

28 Oct 2020

PONE-D-20-29044

Serotonin transporter genotype modulates amygdala resting state perfusion and amygdala reactivity to aversive stimuli depening on sex and estrous cycle stage

PLOS ONE

Dear Dr. Schmitt-Boehrer,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 12 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Tamas Kozicz

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2.  To comply with PLOS ONE submissions requirements, please provide methods of sacrifice in the Methods section of your manuscript.

3.  Thank you for including your ethics statement:

"The present work complies with current regulations regarding animal experimentation in Germany and the EU (European Communities Council Directive 86/609/EEC). All experiments were approved by the local authority and supported by the ‘Animal Welfare Officer’ of the University of Wuerzburg (reference number 55.2-2531.01-81/10).".

i) Please amend your current ethics statement to confirm that your named ethics committee specifically approved this study.

For additional information about PLOS ONE submissions requirements for ethics oversight of animal work, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-animal-research  

ii) Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”).

4. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

Additional Editor Comments (if provided):

Your manuscript has been evaluated by two expert reviewers. They both have raised several major concerns. Specifically they raised serious concerns about study design and statistics.

Please address the reviewers' comments and critique in your revised manuscript and include a point-by-point rebuttal letter with your revised submission.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Angelika G. Schmitt-Boehrer and co-workers combined fMRI and cFos immunohistochemistry to assess the activity in the amygdala upon predator odor exposure in mice. Authors used both female and male wildtype, serotonin transporter knockout and heterozygous mice. The idea to find a correlation between cFos and fMRI signal is interesting. The question, how the cycle of female sex hormones affects the amygdala activity and if this can be detected with these tools is also an important question. There are positive findings which are interesting enough to be published in future, but this reviewer found some major critical points and some minor issues which have to be addressed in order to increase the scientific impact of the manuscript.

Major remarks:

1. Experimental design:

Authors applied 4-6 male mice per genotype for the cFos labeling. This is relatively low, but potentially still acceptable sample size in morphology. Authors included female mice also, but here they processed only two (!) mice for histology. Considering, that the female amygdala is strongly affected by the estrus cycle-related hormonal changes, this sample size does not allow to evaluate the differences related to the hormonal changes accurately. Authors state this limitation multiple times in their manuscript, but stating this problem does not solve it. Because of this, the statement "estrous levels seem to have a tremendous influence on the activity of the amygdala" is not supported by the current work satisfactorily.

2. Statistics:

This issue is strongly linked to the design question (see at remark 1), and to the sample size problem.

A) ANOVA requires normal distribution of data, and homogeneity of variance. Authors are asked to show the statistical tests which approve that the datasets analyzed here, pass these criteria.

B) Also, a reliable power analysis is required here, which supports that one (!) mouse is enough for a neutral odor control. C) Still to statistics, correlation analyses also require a minimal sample size. How was the minimal sample size determined here? Do the datasets meet these criteria?

3. Contradictory statement in the results

Authors say that "estrous cycle stages (proestrus, estrus, metestrus, diestrus) were fairly equally distributed across genotypes" and then they express that "significant distributional difference between estrous cycle stages" occurred, which is contradictory.

4. Authors marked the central amygdala in the histological images, but they encircled the stria terminalis, and a part of the intramygdaloid division of the bed nucleus of the stria terminalis also. This could should be corrected.

5. Authors did not describe the controls for immunohistochemisitry. They did not specify the antibody used (Catalog No missing). If Authors used the same antiserum as used in Ref. 18, this was a well-trusted serum, but Ref. 18 does not say anything about specificity test in mice with this serum either. This should be given.

6. Critics on the concept to search for correlation between fMRI signal, and cFos immunoreactivity

Authors try to find a correlation between cFos immunorectivity and the brain tissue activity as assessed by fMRI tools. This is an exciting and interesting idea, but Authors did not state, consider and discuss an important limitation of the c-Fos mapping (for review see Kovacs KJ Journal of Neuroendocrinology 20, 665–672). One has to consider, that many types of inhibitory neurons do not express this immediate early gene, even, if they are highly active. Therefore, the activation of a particular brain region that is made up mainly by such inhibitory neurons might not be visible as an area with increased c-Fos immunoreactivity in a histological preparation. But, due to the higher metabolic activity of those inhibitory cells, the blood flow might increase. This will in inhibitory areas ultimately weaken or even abolish the correlation between fMRI signal and cFos. Consequently, if one takes into consideration that in many brain areas the proportion of inhibitory (i.e. potentially no cFos expressing) and excitatory (i.e. usually strongly cFos reactive) neurons differs, the strength of the correlation between cFos and fMRI signal will differ from brain area to brain area. Authors may discuss this issue, and check if the strength of correlation between cFos and fMRI is different for each area. It would be also interesting to see and discuss if this is somehow related to the neurochemical character of the neuron populations (and the proportion of those) found in a particular brain area.

Another aspect of the same question is that if a neuron shows electric activity (i.e. it fires), does not necessarily produce more cFos protein. (If neurons would do so, the control, in this case neutral odor group brain tissues, would be highly c-Fos positive also.) The occurrence of c-Fos is estimated in a neuron if the strength of the stimulus is above a certain set point, that induces a higher-order neuronal adaptation initiating changes at transcriptional level. Authors may discuss, if a below-set point-stimulus, that activates the neurons, but, does not induce cFos, may increase the metabolic activity of the cells leading to changes of the blood flow and increased BOLD signal. If this is possible, how does this interfere with the correlation between fMRI and cFos signal?

Minor remarks:

1. Authors may check the manuscript for typos carefully. Some examples: ln. 66. "conncected", ln. 462 "amgydala", ln. 471 "appying".

2. ln. 521. The term "gender" in this context is not the right choice. Instead, this reviewer would suggest to use the term "sex" here.

Question:

What do we know about the olfactory system in this knockout mouse strain? Do they have normal olfactory perception? This question arises since the serotonin transporter is present in the olfactory system (Sur et al 1996 Neuroscinence, pp 217-231). How do we know that -/- and +/- mice do perceive the rat odor properly?

Reviewer #2: In the present study Schmitt-Boehrer et al., used continuous arterial spin labeling (CASL) in combination with c-fos immunohistochemistry for investigating amygdaloid reactivity during baseline conditions or exposure to aversive odor in male and female serotonin transporter (5-HTT) transgenic mice. The authors demonstrated that an aversive odor is associated with blunted reactivity of the amygdala in male 5-HTT +/- and -/- mice compaired to +/+ controls, which corelates with c-fos activation of amygdaloid sub-nuclei. Furthermore, they uncovered that estrous levels in female mice directly influence amygdala perfusion levels. Though these findings are novel and not uninteresting, the manuscript has some matters that needs to be addressed.

Major comments

In the present study the neutral odor control group is of n=1 in both imaging and immunohistochemistry experiments. This is a problem for the statistical relevance of the result, and hence it cannot be used to draw any scientific conclusions. Please either remove the n=1 neutral odor group from all your graphs (i.e. figure 3, figure 4 and 5) or alternatively include more animals in the neutral odor group to reach a proper n-size equivalent to that of your test-groups.

Please include the PS/RS perfusion results in figure 3, as you describe these results in the text p. 15 line 303.

Also, did you observe any changes from RS to PS as individual percental signal changes for each voxel in amygdala? This could be an interesting observation, as you didn’t see any significant changes for RS to SS in Figure 3C.

In the figure 3 legend (p. 16, line 326-328), you mention whole-brain perfusion results, however these are not included in the figure nor described in the results-section - Please revise.

In the results-section 3.5 (p. 19-20, line 384-399) you have omitted the data from figure 5B, please revise.

Minor comments

You have misspelled a word in your title “…depening on sex and estrous cycle stage” should be “….depending on….”.

Please consider revising your title to clarify - i.e. include that these experiments were performed in mice, and shorten if possible.

In the discussion p.22, line 439-440: You are missing something in this sentence, maybe two pronouns, such as “we” and “a”.

In the discussion (p.22 line 443-444), If you want to emphasize the comparison between the neutral odor group and the aversive odor group, please add more animals to the neutral-odor group of the experiment to have sufficient statistical basis for this.

Discussion p. 22, line 448-451, you conclude that the olfactory stimulus is aversive based on amygdala reactivity, this a strong claim without the support from behavioral data such as conditioned place aversion – please revise.

Discussion p. 25-26, line 529-547, consider to leave out the circuitry-discussion as it is not relevant for your study approach, and the discussion is fairly long.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Balazs Gaszner

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Feb 19;16(2):e0247311. doi: 10.1371/journal.pone.0247311.r002

Author response to Decision Letter 0


8 Jan 2021

Thank you very much for your mail informing us about reviewers’ comments to our manuscript entitled “Serotonin transporter genotype modulates amygdala resting state perfusion and amygdala reactivity to aversive stimuli depending on sex and estrous cycle stage” and for the possibility to revise the manuscript according to the reviewers’ suggestions. In addition, we are grateful that we can improve the manuscript according to the PlosOne journal requirements.

Modifications regarding journal requirements:

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Answer:

We adapted the heading style (e.g. removed the numbering) and ensured that throughout the whole manuscript the double-space paragraph format is utilized. We removed ZIP or Postal codes and street addresses from affiliations, and the order of affiliation components had been changed of small to large. Other small changes are related to the spelling of words – e.g. “Fig. 1” had been changed to “Fig 1”. And “Fig. S1” to “S1 Fig”. From the Acknowledgements we removed funding or competing interest information. And we removed the URL from the references.

2. To comply with PLOS ONE submissions requirements, please provide methods of sacrifice in the Methods section of your manuscript.

Answer:

We provided more details about how mice had been sacrificed in the chapter Experimental procedure of the Methods section and wrote as follows: “Two hours after SS onset, mice were sacrificed, according to IACUC standards, by cervical dislocation following a deep anesthesia with isoflurane. Brains were then immediately dissected and processed for subsequent c-Fos immunohistochemical analyses.”

3. Thank you for including your ethics statement:

"The present work complies with current regulations regarding animal experimentation in Germany and the EU (European Communities Council Directive 86/609/EEC). All experiments were approved by the local authority and supported by the ‘Animal Welfare Officer’ of the University of Wuerzburg (reference number 55.2-2531.01-81/10).".

i) Please amend your current ethics statement to confirm that your named ethics committee specifically approved this study. For additional information about PLOS ONE submissions requirements for ethics oversight of animal work, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-animal-research

ii) Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”).

Answer:

We amended our ethics statement to “ The present work complies with current regulations regarding animal experimentation in Germany and the EU (European Communities Council Directive 86/609/EEC). All procedures and protocols have been approved by the committees on the ethics of animal experiments of the University of Würzburg and of the Government of Lower Franconia (license 55.2-2531.01-81/10). Sacrifice was performed under deep isoflurane anesthesia. All efforts were made to minimize suffering.“

4. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

Answer:

We are sorry that we overlooked these data sharing requirements of PlosONE. We removed the phrase „data not shown“ in the manuscript and in the revised version of the manuscript all relevant data are available. We included two Supplemental figures (S1 Fig. And S2 Fig.) with cerebral perfusion levels in whole brain of male (S1 Fig.) and female (S2 Fig.) mice, and provided two supplemental tables with information about descriptive and inferential statistics of fMRI measurements and c-Fos immunohistochemistry using male mice (S1 Table) and of fMRI measurements using female mice (S3 Table).

1) On page 19/20 (pdf-file of the first submission) „Accordingly, when amygdala perfusion levels of the distinct fMRI phases were expressed as a fraction of one another (SS/RS, PS/RS, PS/SS), two-way ANOVA yielded the expected estrous cycle effect on SS/RS (F(1,24)=4.233, p=0.051; proestrus<other stages) (Fig. 5C) and PS/SS (F(1,24)=7.494, p=0.011; proestrus>other stages) (Fig. 5 D) but not on PS/RS (F(1,24)=0.076, p=0.786) (not shown). A less strong effect in the same direction was observed for whole-brain perfusion in female mice (data not shown). Contrary to males, 5-Htt genotype exerted no significant effects in females, neither on RS perfusion nor on odor-induced perfusion level changes in both ROIs (whole brain: data not shown; Amygdala: Fig. 5B).” was changed to “Accordingly, when amygdala perfusion levels of the distinct fMRI phases were expressed as a fraction of one another (SS/RS, PS/RS, PS/SS), two-way ANOVA yielded the expected estrous cycle effect on SS/RS (F(1,22)=6.978, p=0.015; proestrus<other stages) (Fig 5 C) and PS/SS (F(1,22)=8.358, p=0.008; proestrus>other stages) (Fig 5 D) but not on PS/RS (F(1,22)=0.045, p=0.835). Similar results were obtained for whole-brain perfusion, though the effects were much less pronounced. Contrary to males, 5-Htt genotype exerted no significant effects in females, neither on RS perfusion nor on rat odor-induced perfusion level changes in both ROIs (Amygdala: Fig 5B, whole brain: S2 Fig; S3 Table).

2) Moreover, we included the S1 Figure displaying perfusion level changes of whole brain in male mice as well as information about descriptive and inferential statistics of fMRI measurements and c-Fos immunohistochemistry using male mice in the tables of S1 Table.

(On page 16 (pdf-file of the first submission): “In contrast to the amygdala, three-way mixed ANOVA on whole-brain perfusion levels in males detected a highly significant main effect of phase (F(2,56)=17.790, p<0.0001), but no phase x stimulus type (=aversive rat vs. neutral odor) or phase x genotype interaction.” was changed to “Analysis of whole-brain perfusion yielded a highly significant main effect of phase (F(2,52)=46.573, p<0.0001), but no genotype main effect (F(2,26)=3.031, p=0.066) or an interaction between these two factors (F(4,52)=1.860, p=0.131) (S1 Fig, S1 Table).

Answers to the Reviewers:

We are very glad that both reviewers appear to have a favourable impression of our work and consider the results important. We are also very grateful to the reviewers for their thorough analyses of our data, documentation and interpretation and have carefully considered their helpful suggestions. Accordingly, we have tried to adequately address all points of criticism in a revision of our manuscript.

Answers to reviewer 1:

Reviewer:

1. Experimental design: Authors applied 4-6 male mice per genotype for the cFos labeling. This is relatively low, but potentially still acceptable sample size in morphology. Authors included female mice also, but here they processed only two (!) mice for histology. Considering, that the female amygdala is strongly affected by the estrus cycle-related hormonal changes, this sample size does not allow to evaluate the differences related to the hormonal changes accurately. Authors state this limitation multiple times in their manuscript, but stating this problem does not solve it. Because of this, the statement "estrous levels seem to have a tremendous influence on the activity of the amygdala" is not supported by the current work satisfactorily.

Answer:

We thank the reviewer for this helpful criticism. We decided to completely remove chapter 3.6 of the original submission (page 21 of PONE-S-20-35131_15.09.2020.pdf) with c-Fos in females.

We only mentioned at the end of the overall results part that „The number of c-Fos-ir cells in the amygdala of females appear to be highest in 5-HTT +/+ animals (S3 Fig.). However, due to the small sample size of investigated females (n=6) and the potential influence of their estrous cycle stage it is impossible to draw any valid conclusions.“

With regard to females, we will now focus on showing the results of fMRI perfusion. A group size of n = 9-10 females was available for fMRI experiments.

Reviewer:

2. Statistics: This issue is strongly linked to the design question (see at remark 1), and to the sample size problem.

A) ANOVA requires normal distribution of data, and homogeneity of variance. Authors are asked to show the statistical tests which approve that the datasets analyzed here, pass these criteria. B) Also, a reliable power analysis is required here, which supports that one (!) mouse is enough for a neutral odor control. C) Still to statistics, correlation analyses also require a minimal sample size. How was the minimal sample size determined here? Do the datasets meet these criteria?

Answer:

To A) In two supplement tables we now provide descriptive and inferential statistics of fMRI measurements and c-Fos immunohistochemistry with male mice of different 5-Htt genotypes (S1 Table) and solely of fMRI measurements with female mice of different 5-Htt genotypes (S3 Table). In these S Tables we provide, inter alia, the results of the Shapiro-Wilk test of normality and the Levene’s test for homogeneity of variances. Moreover, in ANOVAs with repeated measures Mauchly’s test was applied to determine whether the assumption of sphericity has been met. As in a few cases the homogeneity of the variance and/or the normal distribution was violated, we applied the Welch's ANOVA (which can be used even when the groups have unequal variances) followed by Games-Howell post hoc tests (instead of Bonferroni post hoc tests) in these cases. Corresponding results is provided in S1 Table and in S3 Table. In „Data analysis“ of the Material and Methods section we now provide more details of statistical tests used.

To B) As Reviewer 2 also suggested, we removed the n=1 neutral odor group from all statistical analyses and from all our graphs. That`s why, it is not necessary to perform a power analysis anymore. To C) We had a sample size of n=13 for performing a Product moment correlation according to Pearson. The calculated statistical power with n=13, a significance level (denoted by alpha) of 0.05 and the different Pearson correlation coefficients of La, BL, and Ce (see results part on page 17) was 0.8 (La), 0.9 (BL), and 0.68 (Ce). A value of around .8 -.9 is usually recommended.

Reviewer:

3. Contradictory statement in the results. Authors say that "estrous cycle stages (proestrus, estrus, metestrus, diestrus) were fairly equally distributed across genotypes" and then they express that "significant distributional difference between estrous cycle stages" occurred, which is contradictory…

Answer:

We added the term “irrespective of the 5-Htt-genotype” to the sentence in question to make clear that this statement is not contradictory. „The four different estrous cycle stages (proestrus, estrus, metestrus, diestrus) were fairly equally distributed across genotypes (χ2(6)=5.527, p=0.478; n= 28; S2 Table). Overall, however, the proestrus stage greatly predominated over the other stages (χ2(3)=20.571, p<0.001; S2 Table). Given the significant distributional difference between estrous cycle stages (irrespective of the 5-Htt-genotype) and the fact that …”

Reviewer:

4. Authors marked the central amygdala in the histological images, but they encircled the stria terminalis, and a part of the intramygdaloid division of the bed nucleus of the stria terminalis also. This could should be corrected.

Answer:

Many thanks for your careful viewing of these figures. You are absolutely right, we have outlined this region too generously and therefore not properly/correctly. We have now adjusted the lines that border the central amygdala.

Reviewer:

5. Authors did not describe the controls for immunohistochemisitry. They did not specify the antibody used (Catalog No missing). If Authors used the same antiserum as used in Ref. 18, this was a well-trusted serum, but Ref. 18 does not say anything about specificity test in mice with this serum either. This should be given.

Answer:

We used the same antibody purchased from Santa Cruz Biotechnology in Karabeg et al., 2013 (Re. 18) and in Auth et al., 2018. Unfortunately, this antibody has been discontinued in the meantime.

Regarding specificity tests, we compared obtained c-Fos staining results with using available brains of differently stressed mice at the sub-cellular, cellular, and regional level with already published c-Fos staining results. Of course, so called No-Primary-Controls with omitting primary antibody incubation were performed.

In the Material and Methods section we provide now more information:

1) The Catalog No. Sc-52 is added.

2) No-Primary-Controls with omitting primary antibody incubation were performed and always resulted in the absence of any staining. In addition, positive-tissue-controls had been performed to verify the specifity of c-Fos immunoreactivity at the sub-cellular, cellular, and regional level.

Reviewer:

6. Critics on the concept to search for correlation between fMRI signal, and cFos immunoreactivity Authors try to find a correlation between cFos immunorectivity and the brain tissue activity as assessed by fMRI tools. This is an exciting and interesting idea, but Authors did not state, consider and discuss an important limitation of the c-Fos mapping (for review see Kovacs KJ Journal of Neuroendocrinology 20, 665–672). One has to consider, that many types of inhibitory neurons do not express this immediate early gene, even, if they are highly active. Therefore, the activation of a particular brain region that is made up mainly by such inhibitory neurons might not be visible as an area with increased c-Fos immunoreactivity in a histological preparation. But, due to the higher metabolic activity of those inhibitory cells, the blood flow might increase. This will in inhibitory areas ultimately weaken or even abolish the correlation between fMRI signal and cFos. Consequently, if one takes into consideration that in many brain areas the proportion of inhibitory (i.e. potentially no cFos expressing) and excitatory (i.e. usually strongly cFos reactive) neurons differs, the strength of the correlation between cFos and fMRI signal will differ from brain area to brain area. Authors may discuss this issue, and check if the strength of correlation between cFos and fMRI is different for each area. It would be also interesting to see and discuss if this is somehow related to the neurochemical character of the neuron populations (and the proportion of those) found in a particular brain area. Another aspect of the same question is that if a neuron shows electric activity (i.e. it fires), does not necessarily produce more cFos protein. (If neurons would do so, the control, in this case neutral odor group brain tissues, would be highly c-Fos positive also.) The occurrence of c-Fos is estimated in a neuron if the strength of the stimulus is above a certain set point, that induces a higher-order neuronal adaptation initiating changes at transcriptional level. Authors may discuss, if a below-set point-stimulus, that activates the neurons, but, does not induce cFos, may increase the metabolic activity of the cells leading to changes of the blood flow and increased BOLD signal. If this is possible, how does this interfere with the correlation between fMRI and cFos signal?

Answer:

Many thanks for your comment. Looking through the literature, we can confirm some of your concerns, for example that the transcription factor c-Fos is differently regulated in different brain regions, and that the time-course of Fos induction and decay varies with different inducing stimuli (aversive stimuli as well as positive stimuli, e.g. different housing conditions – Robins et al., 2020); and that some brain regions do not seem to express Fos after any treatments already tried (Dragunov and Feull, 1989).

But we couldn`t comprehend/retrace your statement that „that many types of inhibitory neurons do not express this immediate early gene“. Staiger and coworkers (2002) wrote that „By morphological phenotyping with intracellular Lucifer Yellow injections, it was found that a large majority were probably excitatory pyramidal cells, but inhibitory interneurons were also found to contain c-Fos-immunoreactive nuclei.“ The fact that we detected in our study many more c-Fos-positive cells in the striatum-like central nucleus of the amygdala (Ce) composed mainly of GABAergic neurons than in the cortex-like basolateral amygdala (BLA) with around 80% glutamatergic principal neurons and roughly 20% GABAergic interneurons confirms this statement. This could implicate that in our study in consequence of rat odor exposure the the number of c-Fos-positive Ce inhibitory neurons is higher than in the Ce of mice exposed to the neutral odor (as shown in Fig. 4A and B). But, of course, this is not proofen, as we did not further characterize these c-Fos-ir neurons in all three investigated amygdaloid nuclei e.g. via immunofluorescence double labelings of c-Fos with marker for GABAergic and glutamatergic neurons (unfortunately, not enough tissue sections hab been available).

Therefore, I would agree to the statement of Kovacs and coworkers (2008) that „In spite of these limitations, the use of c-Fos and other regulatory- or effector transcription factors as markers of neuronal activation will continue to be an extremely powerful technique“. But, of course, we have to be careful with our conclusions as heterogeneity of cellular activation in functionally distinct parts of the brain exist and cannot always be mapped perfectly by the detection of c-Fos.

Regarding the strength of correlation between cFos and fMRI in all three investigated amygdaloid subnuclei: correlation was shown to be highly significant in the basolateral (BL) nucleus of the amygdala (p=0.001), and correlation was shown to be significant in the lateral (La) and central (Ce) nucleus of the amygdala (p=0.021 and p=0.037, respectively). Therefore, the different levels of significance of the correlation analyses do not reflect the type and composition of the amygdaloid nuclei analyzed, at least in our study, as La and BL have approximately 80% glutamatergic principal neurons and roughly 20% GABAergic interneurons, wheras the Ce is composed mainly of GABAergic neurons. But, it is certain that the weakest correlation could be detected in the Ce. In the discussion we pointed to possible challenges with the interpretation of c-Fos as a marker for neural activation and its use for correlation analyses.

Reviewer:

7. Minor remarks:

I. Authors may check the manuscript for typos carefully. Some examples: ln. 66. "conncected", ln. 462 "amgydala", ln. 471 "appying".

Answer:

We carefully checked the manuscript for typos and corrected them.

II. ln. 521. The term "gender" in this context is not the right choice. Instead, this reviewer would suggest to use the term "sex" here.

Answer:

According to the reviewer`s suggestion we substituted the word “gender” by the more appropriate word „sex“.

Reviewer: Question: What do we know about the olfactory system in this knockout mouse strain? Do they have normal olfactory perception? This question arises since the serotonin transporter is present in the olfactory system (Sur et al 1996 Neuroscinence, pp 217-231). How do we know that -/- and +/- mice do perceive the rat odor properly?

Answer:

The 5-HTT is widely distributed in the brain and can be detected in almost all brain regions. Also the olfactory bulb is densely innervated by serotonergic fibers. From several published works dealing with odor exposure and its behavioral consequences using the 5-HTT knockout mouse line we conclude that olfactory perception seems to be normal in 5-HTT-deficient mice. This assumption is supported inter alia by the the study of Adamec and coworkers (2006), who found out that predator odor exposure (in this case: cat odor) resulted in increased anxiety-related behavior in 5-HTT-deficient mice. This change in fear-like behavior requires that these mice can smell the predator odor.

Carlson and coworkers showed that near elimination of 5-HT from the forebrain, including the olfactory bulbs, had no detectable effect on the ability of mice to perform the olfactory go/no-go task and concluded that HT neurotransmission is not necessary for the most essential aspects of olfaction (Carlson et al., 2006). However, optogenetic activation of DRN serotonergic neurons decreases odor-evoked responses in pyramidal neurons oft he anterior piriform cortex, a region important for olfactory learning and encoding of odor identity and intensity (Wang et al., 2019). To sum up, the role of 5-HT in olfaction is still under debate and should be the target of further investigations.

In the introduction, page 4, the following sentence had been added: “A previous study shows that olfactory perception is unaltered in 5-HTT-deficient mice (22).

Answers to reviewer 2:

Reviewer:

1. In the present study the neutral odor control group is of n=1 in both imaging and immunohistochemistry experiments. This is a problem for the statistical relevance of the result, and hence it cannot be used to draw any scientific conclusions. Please either remove the n=1 neutral odor group from all your graphs (i.e. figure 3, figure 4 and 5) or alternatively include more animals in the neutral odor group to reach a proper n-size equivalent to that of your test-groups.

Answer:

As it is not possible for us to add more mice to the neutral odor group, we decided to completely remove this group from perfusion level analyses and adapted all statistical data as the reviewer suggested. However, we still show an image representing the results of c-Fos immunohistochemistry using brain tissue from mice exposed to neutral odor (Fig 4B). Using this qualitative approach we could display differences in the number of c-Fos-immunoreactive cells in the amygdala of mice exposed to rat odor compared to mice exposed to neutral odor (Fig 4A vs. 4B).

Reviewer:

2. Please include the PS/RS perfusion results in figure 3, as you describe these results in the text p. 15 line 303.

Answer:

As suggested by the reviewer, we included the PS/RS perfusion results in Fig 3. Graph C in Fig 3 displays these results.

Reviewer:

3. Also, did you observe any changes from RS to PS as individual percental signal changes for each voxel in amygdala? This could be an interesting observation, as you didn’t see any significant changes for RS to SS in Figure 3C.

Answer:

The reviewer is absolutely right, that a visual representation of perfusion changes from RS to PS would be interesting as well. However, since statistical analyzes did not reveal major differences between SS/RS (FIG. 3B) and PS/SS (FIG. 3C), we have restricted ourselves to the representation of SS/RS. This individual voxel-based calculation of amygdala perfusion level changes depicted in colors corresponding to different values simply demonstrates different levels of perfusion level changes in mice of different 5-Htt genotypes. Moreover, the generation of such visual representations of perfusion level changes is a very complex process and very time consuming. But of course we cannot be sure whether visual representations of perfusion changes from RS to PSwould not have brought new knowledge.

Reviewer:

4. In the figure 3 legend (p. 16, line 326-328), you mention whole-brain perfusion results, however these are not included in the figure nor described in the results-section - Please revise.

Answer:

Thank you for reading the manuscript so carefully. This sentence was not intended to be part of the figure legend. To avoid misunderstandings we have moved this sentence in question to the front of the legend of Figure 3. We have improved the results in this sentence (adapted to the revised statistical approach), and provided information that the whole brain results are available in the supplement (S1 Fig, S1 Table).

Reviewer:

5. In the results-section 3.5 (p. 19-20, line 384-399) you have omitted the data from figure 5B, please revise.

Answer:

Again, thank you for reading the manuscript so carefully. In the originally submitted version of the manuscript data from Fig 5B had been provided after the Figure legend, which, however, had been very unfavorable. We have moved the sentence in question to the front of the legend of Fig 5.

Minor comments:

Reviewer:

You have misspelled a word in your title “…depening on sex and estrous cycle stage” should be “….depending on….”.

Answer:

We have corrected this typo.

Reviewer:

Please consider revising your title to clarify - i.e. include that these experiments were performed in mice, and shorten if possible.

Answer:

We changed the title to: “Serotonin transporter genotype modulates resting state and predator stress-induced amygdala perfusion in mice in a sex-dependent manner”.

Reviewer:

In the discussion p.22, line 439-440: You are missing something in this sentence, maybe two pronouns, such as “we” and “a”.

Answer:

We changed this sentence to: “Subsequently we performed a c-Fos immunohistochemistry study to demonstrate activation at cellular level.”

Reviewer:

In the discussion (p.22 line 443-444), If you want to emphasize the comparison between the neutral odor group and the aversive odor group, please add more animals to the neutral-odor group of the experiment to have sufficient statistical basis for this.

Answer:

As already mentioned above we decided to completely remove this neutral odor group as it is not possible for us to add more mice to this group, and adapted all statistical data as the reviewer suggested.

Reviewer:

Discussion p. 22, line 448-451, you conclude that the olfactory stimulus is aversive based on amygdala reactivity, this a strong claim without the support from behavioral data such as conditioned place aversion – please revise.

Answer:

The reviewer is right, that we did not show such a behavioral outcome of exposing the experimental mice to the rat odor we used as predator scent in our fMRI study. We can only provide an indirect proof of the aversive nature of the used rat odor. As it is mentioned in the introduction and in the discussion, several studies have already shown that mice being exposed to rat predator scents exhibit innate defensive behaviors including flight and freezing as well as an increase in stress hormone levels(35–39). Furthermore, predator odors were shown to evoke an increase in the immediate early gene (IEG) product c-Fos in the BL, Ce and medial nucleus in rodents(40–42). And even if we could not use these mice exposed to neutral odor for proper quantitative analyses (as the group size was much too low), we could show representative images with much more c-Fos positive cells in the amygdala of rat-odor-exposed mice than in the amygdala of neutral-odor-exposed mice on a qualitative level (see Fig. 4A and B).

Reviewer:

Discussion p. 25-26, line 529-547, consider to leave out the circuitry-discussion as it is not relevant for your study approach, and the discussion is fairly long.

Answer:

We think that taking a closer look on neurobiological mechanisms in general and on compensatory mechansims already described to exist in the brain of 5-HTT-deficient mice in particular, that could be involved in the perfusion level changes in the amygdala of mice with different 5-Htt genotypes, will help to understand possible underlying mechanisms. But you are right, that the biggest part of this circuit discussion does not aid in understanding the fMRI results. We removed a few sentences on page 23 of the revised manuscript without track changes, and on pages 28-29 of the manuscript with track changes.

We would like to again thank the reviewers and the editor for all the effort they put into studying our manuscript. We feel that the manuscript has been improved by the changes we carried out according to the reviewers’ helpful suggestions, and hope that their concerns have been answered.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Tamas Kozicz

5 Feb 2021

Title: Serotonin transporter genotype modulates resting state and predator stress-induced amygdala perfusion in mice in a sex-dependent manner

PONE-D-20-29044R1

Dear Dr. Schmitt-Boehrer,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Tamas Kozicz

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: All concerns of this reviewer were excellently addressed. The question on olfactory function of the mouse strain used was also answered. After reading the revised version of the manuscript, no new critical remarks emerged.

Reviewer #2: The authors have addressed the reviewer questions in a satisfactory manner. The manuscript is in its current state suited for publication.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Balazs Gaszner, MD, PhD

Reviewer #2: No

Acceptance letter

Tamas Kozicz

11 Feb 2021

PONE-D-20-29044R1

Serotonin transporter genotype modulates resting state and predator stress-induced amygdala perfusion in mice in a sex-dependent manner

Dear Dr. Schmitt-Böhrer:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Tamas Kozicz

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Cerebral perfusion levels in whole brain of male mice are not influenced by the 5-Htt genotype.

    Cerebral perfusion levels during resting state (RS), stimulation state (SS) and post-stimulation state (PS) in whole brain of male mice of all three 5-Htt genotypes. Data represent mean perfusion level ± SEM.

    (TIF)

    S2 Fig. Cerebral perfusion levels in whole brain of female (B) mice are not influenced by the 5-Htt genotype.

    Cerebral perfusion levels during different fMRI states in whole brain of female mice of all three 5-Htt genotypes depending on their estrous stage receiving an aversive odor during SS. Data represent mean perfusion level ± SEM.

    (TIF)

    S3 Fig. Density of c-Fos-immunoreactive cells in the investigated amygdaloid nuclei with aversive odor presentation during fMRI experiment.

    (A, B, C): Individual and mean density of c-Fos-immunoreactive cells (number of c-Fos-ir cells per μm2) in the lateral, basolateral and central amygdaloid nucleus of female mice with aversive rat odor exposure.

    (TIF)

    S1 Table. Descriptive and inferential statistics of fMRI measurements with male mice of different 5-Htt genotypes.

    (DOCX)

    S2 Table. Estrous cycle staging in female mice.

    (DOCX)

    S3 Table. Descriptive and inferential statistics of fMRI measurements with female mice of different 5-Htt genotypes.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES